FILIPPO DRAGO
Indici Bibliometrici:
Peer review papers = 548
Citazioni = 13997 (Scopus); 18694 (Scholar)
H-index = 57 (Scopus); 68 (Scholar)
LISTA PUBBLICAZIONI:
(04/2022)
548. Brancati, S., Gozzo, L., Romano, G.L., Vetro, C., Dulcamare, I., Maugeri, C., Parisi, M., Longo, L., Vitale, D.C., Di Raimondo, F., Drago, F. Venetoclax in relapsed/refractory acute myeloid leukemia: Are supporting evidences enough? (2022) Cancers, 14 (1), art. no. 22, IF 6.102.
547. Barbagallo, C., Platania, C.B.M., Drago, F., Barbagallo, D., Di Pietro, C., Purrello, M., Bucolo, C., Ragusa, M. Do extracellular RNAs provide insight into uveal melanoma biology?
(2021) Cancers, 13 (23), art. no. 5919, IF 6.102.
546. Stark, T., Di Martino, S., Drago, F., Wotjak, C.T., Micale, V. Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment (2021) Pharmacological Research, 174, art. no. 105938, IF 7.658.
545. Lazzara, F., Amato, R., Platania, C.B.M., Conti, F., Chou, T.-H., Porciatti, V., Drago, F., Bucolo, C. 1α,25-dihydroxyvitamin D3 protects retinal ganglion cells in glaucomatous mice (2021) Journal of Neuroinflammation, 18 (1), art. no. 206, IF 7.573.
544. Benfatto, G., Drago, F., Regulatory Group, Ethics Committee Catania 1 (Group)
Correction to: Regulatory, scientific, and ethical issues arising from institutional activity in one of the 90 Italian Research Ethics Committees (BMC Medical Ethics, (2021), 22, 1, (40), 10.1186/s12910-021-00605-7) (2021) BMC Medical Ethics, 22 (1), art. no. 52, IF 2.652.
543. Benfatto, G., Drago, F., Longo, L., Mansueto, S., Gozzo, L., Vitale, D.C., Amato, S., Basile, F., Blanco, A., Borzì, V., Cavallaro, P., Cilia, S., Conti, M., Cristaudo, C., Daidone, L.D., Di Fazzio, S., Di Mauro, M., Garozzo, R., Giardina, G., Gulino, A., Iachelli, L., La Bella, M.L., La Rosa, A., Lazzara, A., Leonardi, F., Lo Monaco, F., Malatino, L., Mattina, T., Negro, M., Palermo, F., Puleo, S., Raciti, R., Ruggieri, M., Sapuppo, A., Scillieri, R., Squatrito, S., Tanasi, F., Regulatory Group, Ethics Committee Catania 1 (Group) Regulatory, scientific, and ethical issues arising from institutional activity in one of the 90 Italian Research Ethics Committees (2021) BMC Medical Ethics, 22 (1), art. no. 40, IF 2.652.
542. O’Leary, R., Polosa, R., Li Volti, G., Alaimo, S., Anfuso, C.D., Barbagallo, I., Basile, F., Battiato, S., Bertino, G., Bianchi, A., Biondi, A.G., Brandi, M.L., Cacciola, E., Cacciola, R.R., Cacopardo, B.S., Calogero, A.E., Cambria, M.T., Campagna, D., Caraci, F., Cariola, A., Caruso, M., Caponnetto, P., Cibella, F., Di Mauro, M., Di Nuovo, S., Di Stefano, A., Drago, F., Failla, S., Faraci, R., Ferlito, S., Ferrante, M., Ferro, A., Ferro, G.A., Frasca, F., Frittitta, L., Furneri, P.M., Gallo, G., Galvano, F., Gagliano, A., Grasso, G., Guarino, F., Gulino, A., Jannini, E.A., Vignera, S.L.A., Lazzarino, G., Longo, A., Lupo, G., Malerba, M., Marletta, L., Nicolosi, G., Nocera, F., 541. Oliveri Conti, G., Parenti, R., Pulvirenti, A., Purrello, F., Rapisarda, F., Rapisarda, V., Reibaldi, M., Rizzo, R., Ronsisvalle, S., Ruggieri, M., Santagati, M.C., Satriano, C., Sciacca, L., Signorelli, M.S., Tatullo, M., Tibullo, D., Tomaselli, V., Zanoli, L., Zappalà, A., the Center of Excellence for the Acceleration of Harm Reduction (CoEHAR) Critical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electronic cigarettes (2021) Harm Reduction Journal, 18 (1), art. no. 31, IF 3.9.
540. Preti, A., Demontis, R., Cossu, G., Kalcev, G., Cabras, F., Moro, M.F., Romano, F., Balestrieri, M., Caraci, F., Dell’Osso, L., Di Sciascio, G., Drago, F., Hardoy, M.C., Roncone, R., Faravelli, C., Gonzalez, C.I.A., Angermayer, M., Carta, M.G. The lifetime prevalence and impact of generalized anxiety disorders in an epidemiologic Italian National Survey carried out by clinicians by means of semi-structured interviews (2021) BMC Psychiatry, 21 (1), art. no. 48, IF 3.388.
539. Gozzo, L., Vetro, C., Brancati, S., Longo, L., Vitale, D.C., Romano, G.L., Mauro, E., Fiumara, P.F., Maugeri, C., Parisi, M.S., Dulcamare, I., Garibaldi, B., Duminuco, A., Palumbo, G.A., Di Raimondo, F., Drago, F. Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database (2021) Frontiers in Pharmacology, 12, art. no. 748766, IF 5.81.
538. Lazzara, F., Conti, F., Platania, C.B.M., Eandi, C.M., Drago, F., Bucolo, C. Effects of Vitamin D3 and Meso-Zeaxanthin on Human Retinal Pigmented Epithelial Cells in Three Integrated in vitro Paradigms of Age-Related Macular Degeneration (2021) Frontiers in Pharmacology, 12, art. no. 778165, IF 5.81.
537. D’Urso, O., Drago, F. Pharmacological significance of extra-oral taste receptors
(2021) European Journal of Pharmacology, 910, art. no. 174480, IF 4.432.
536. Gozzo, L., Romano, G.L., Romano, F., Brancati, S., Longo, L., Vitale, D.C., Drago, F.
Health Technology Assessment of Advanced Therapy Medicinal Products: Comparison Among 3 European Countries (2021) Frontiers in Pharmacology, 12, art. no. 755052, IF 5.81.
535. Toro, M.D., Gozzo, L., Tracia, L., Cicciù, M., Drago, F., Bucolo, C., Avitabile, T., Rejdak, R., Nowomiejska, K., Zweifel, S., Yousef, Y.A., Nazzal, R., Romano, G.L. New therapeutic perspectives in the treatment of uveal melanoma: A systematic review (2021) Biomedicines, 9 (10), art. no. 1311, IF 5.612.
534. Furneri, G., Platania, S., Privitera, A., Martelli, F., Smeriglio, R., Razza, G., Maci, T., Castellano, S., Drago, F., Santagati, M., Caponnetto, P., Caraci, F., Di Nuovo, S. The apathy evaluation scale (Aes-c): Psychometric properties and invariance of italian version in mild cognitive impairment and alzheimer’s disease (2021) International Journal of Environmental Research and Public Health, 18 (18), art. no. 9597, IF 3.364.
533. Genchi, G.G., Degl’innocenti, A., Martinelli, C., Battaglini, M., De Pasquale, D., Prato, M., Marras, S., Pugliese, G., Drago, F., Mariani, A., Balsamo, M., Zolesi, V., Ciofani, G. Cerium Oxide Nanoparticle Administration to Skeletal Muscle Cells under Different Gravity and Radiation Conditions (2021) ACS Applied Materials and Interfaces, 13 (34), pp. 40200-40213, IF 9.229
532. Maldonado, R., Drago, F. Editorial: Drug Repurposing for COVID-19 Therapy (2021) Frontiers in Pharmacology, 12, art. no. 748886, IF 5.81.
531. Bucolo, C., Barbieri, A., Viganò, I., Marchesi, N., Bandello, F., Drago, F., Govoni, S., Zerbini, G., Pascale, A. Short-and Long-Term Expression of Vegf: A Temporal Regulation of a Key Factor in Diabetic Retinopathy (2021) Frontiers in Pharmacology, 12, art. no. 707909, IF 5.81.
530. Zeng, J., Fontana, M., Castellino, M., Sacco, A., Farkhondehfal, M.A., Drago, F., Pirri, C.F. Efficient co2 electroreduction on tin modified cuprous oxide synthesized via a one-pot microwave-assisted route (2021) Catalysts, 11 (8), art. no. 907, IF 3.934.
529. Conti, F., Romano, G.L., Eandi, C.M., Toro, M.D., Rejdak, R., Di Benedetto, G., Lazzara, F., Bernardini, R., Drago, F., Cantarella, G., Bucolo, C. Brimonidine is Neuroprotective in Animal Paradigm of Retinal Ganglion Cell Damage (2021) Frontiers in Pharmacology, 12, art. no. 705405, IF 5.81.
528. Brancati, S., Gozzo, L., Longo, L., Vitale, D.C., Drago, F. Rituximab in Multiple Sclerosis: Are We Ready for Regulatory Approval? (2021) Frontiers in Immunology, 12, art. no. 661882, IF 7.561.
527. Di Marco, B., Dell’Albani, P., D’Antoni, S., Spatuzza, M., Bonaccorso, C.M., Musumeci, S.A., Drago, F., Bardoni, B., Catania, M.V. Fragile X mental retardation protein (FMRP) and metabotropic glutamate receptor subtype 5 (mGlu5) control stress granule formation in astrocytes (2021) Neurobiology of Disease, 154, art. no. 105338, IF 5.996.
526. Maugeri, G., Bucolo, C., Drago, F., Rossi, S., Di Rosa, M., Imbesi, R., D’Agata, V., Giunta, S.
Attenuation of High Glucose-Induced Damage in RPE Cells through p38 MAPK Signaling Pathway Inhibition (2021) Frontiers in Pharmacology, 12, art. no. 684680, IF 5.81.
525. Maurel, O.M., Torrisi, S.A., Barbagallo, C., Purrello, M., Salomone, S., Drago, F., Ragusa, M., Leggio, G.M. Dysregulation of mir-15a-5p, mir-497a-5p and mir-511-5p is associated with modulation of bdnf and fkbp5 in brain areas of ptsd-related susceptible and resilient mice
(2021) International Journal of Molecular Sciences, 22 (10), art. no. 5157, IF 5.542.
524. Caruso, G., Benatti, C., Musso, N., Fresta, C.G., Fidilio, A., Spampinato, G., Brunello, N., Bucolo, C., Drago, F., Lunte, S.M., Peterson, B.R., Tascedda, F., Caraci, F. Carnosine protects macrophages against the toxicity of aβ1-42 oligomers by decreasing oxidative stress (2021) Biomedicines, 9 (5), art. no. 477, IF 5.612.
523. Kamińska, A., Romano, G.L., Rejdak, R., Zweifel, S., Fiedorowicz, M., Rejdak, M., Bajka, A., Amato, R., Bucolo, C., Avitabile, T., Drago, F., Toro, M.D. Influence of trace elements on neurodegenerative diseases of the eye—the glaucoma model (2021) International Journal of Molecular Sciences, 22 (9), art. no. 4323, IF 5.542.
522. Torrisi, S.A., Lavanco, G., Maurel, O.M., Gulisano, W., Laudani, S., Geraci, F., Grasso, M., Barbagallo, C., Caraci, F., Bucolo, C., Ragusa, M., Papaleo, F., Campolongo, P., Puzzo, D., Drago, F., Salomone, S., Leggio, G.M. A novel arousal-based individual screening reveals susceptibility and resilience to PTSD-like phenotypes in mice (2021) Neurobiology of Stress, 14, art. no. 100286, IF 5.441.
521. Trotta, M.C., Gesualdo, C., Platania, C.B.M., De Robertis, D., Giordano, M., Simonelli, F., D’Amico, M., Drago, F., Bucolo, C., Rossi, S. Circulating miRNAs in diabetic retinopathy patients: Prognostic markers or pharmacological targets? (2021) Biochemical Pharmacology, 186, art. no. 114473, IF 5.585.
520. Leggio, G.M., Torrisi, S.A., Mastrogiacomo, R., Mauro, D., Chisari, M., Devroye, C., Scheggia, D., Nigro, M., Geraci, F., Pintori, N., Giurdanella, G., Costa, L., Bucolo, C., Ferretti, V., Sortino, M.A., Ciranna, L., De Luca, M.A., Mereu, M., Managò, F., Salomone, S., Drago, F., Papaleo, F. The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher order cognitive functions in mice and humans (2021) Molecular Psychiatry, 26 (4), pp. 1272-1285, IF 15.992.
519. Brancati, S., Gozzo, L., Longo, L., Vitale, D.C., Russo, G., Drago, F. Fertility Preservation in Female Pediatric Patients With Cancer: A Clinical and Regulatory Issue (2021) Frontiers in Oncology, 11, art. no. 641450, IF 6.244 .
518. Feste, P.D., Crisci, M., Barbon, F., Tajoli, F., Salerno, M., Drago, F., Prato, M., Gross, S., Gatti, T., Lamberti, F. Work function tuning in hydrothermally synthesized vanadium-doped MoO3 and Co3O4 mesostructures for energy conversion devices (2021) Applied Sciences (Switzerland), 11 (5), art. no. 2016, pp. 1-13, IF 0.773.
517.Cimino, C., Maurel, O.M., Musumeci, T., Bonaccorso, A., Drago, F., Souto, E.M.B., Pignatello, R., Carbone, C. Essential oils: Pharmaceutical applications and encapsulation strategies into lipid-based delivery systems (2021) Pharmaceutics, 13 (3), art. no. 327, pp. 1-35, IF 6.072.
516. Zingales, V., Torrisi, S.A., Leggio, G.M., Bucolo, C., Drago, F., Salomone, S. Pharmacological and genetic evidence of dopamine receptor 3-mediated vasoconstriction in isolated mouse aorta (2021) Biomolecules, 11 (3), art. no. 418, pp. 1-13, IF 4.569.
515.Di Bartolomeo, M., Stark, T., Maurel, O.M., Iannotti, F.A., Kuchar, M., Ruda-Kucerova, J., Piscitelli, F., Laudani, S., Pekarik, V., Salomone, S., Arosio, B., Mechoulam, R., Maccarrone, M., Drago, F., Wotjak, C.T., Di Marzo, V., Vismara, M., Dell’Osso, B., D’Addario, C., Micale, V. Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats (2021) Pharmacological Research, 164, art. no. 105357, IF 7.658.
514. Vásquez, L., Davis, A., Gatto, F., Ngoc An, M., Drago, F., Pompa, P.P., Athanassiou, A., Fragouli, D. Multifunctional PDMS polyHIPE filters for oil-water separation and antibacterial activity (2021) Separation and Purification Technology, 255, art. no. 117748, IF 7.312.
513. Furneri, G., Razza, G., Santagati, M., Drago, F., Nuovo, S.D., Caraci, F. The link between apathy and Alzheimer’s Disease: The role of psychometric tools and the possible implications for treatment (2021) Life Span and Disability, 24 (1), pp. 85-111, IF 1.88.
512. Preti, A., Piras, M., Cossu, G., Pintus, E., Pintus, M., Kalcev, G., Cabras, F., Moro, M.F., Romano, F., Balestrieri, M., Caraci, F., Dell’Osso, L., Di Sciascio, G., Drago, F., Hardoy, M.C., Roncone, R., Faravelli, C., Musu, M., Finco, G., Nardi, A.E., Carta, M.G. The burden of agoraphobia in worsening quality of life in a community survey in Italy (2021) Psychiatry Investigation, 18 (4), pp. 277-283, IF 2.505.
511. Boulkrane, M.S., Ilina, V., Melchakov, R., Fedotova, J., Drago, F., Gozzo, L., Das, U.N., Abd El-Aty, A.M., Baranenko, D. COVID-19 Disease and Vitamin D: A Mini-Review
(2020) Frontiers in Pharmacology, 11, art. no. 604579, IF 5.81.
510. Bonfiglio, V., Platania, C.B.M., Lazzara, F., Conti, F., Pizzo, C., Reibaldi, M., Russo, A., Fallico, M., Ortisi, E., Pignatelli, F., Longo, A., Avitabile, T., Drago, F., Bucolo, C. Tgf-β serum levels in diabetic retinopathy patients and the role of anti-vegf therapy (2020) International Journal of Molecular Sciences, 21 (24), art. no. 9558, pp. 1-16, IF 5.924.
509. Caruso, G., Grasso, M., Fidilio, A., Tascedda, F., Drago, F., Caraci, F. Antioxidant properties of second-generation antipsychotics: Focus on microglia (2020) Pharmaceuticals, 13 (12), art. no. 457, pp. 1-20, IF 5.863.
508. Fresta, C.G., Caruso, G., Fidilio, A., Platania, C.B.M., Musso, N., Caraci, F., Drago, F., Bucolo, C. Dihydrotanshinone, a natural diterpenoid, preserves blood-retinal barrier integrity via p2x7 receptor (2020) International Journal of Molecular Sciences, 21 (23), art. no. 9305, pp. 1-21 IF 5.924.
507. Najafi, L., Bellani, S., Oropesa-Nuñez, R., Brescia, R., Prato, M., Pasquale, L., Demirci, C., Drago, F., Martín-García, B., Luxa, J., Manna, L., Sofer, Z., Bonaccorso, F. Microwave-Induced Structural Engineering and Pt Trapping in 6R-TaS2 for the Hydrogen Evolution Reaction (2020) Small, 16 (50), art. no. 2003372, IF 13.281.
506. Malaguarnera, G., Catania, V.E., Latteri, S., Borzì, A.M., Bertino, G., Madeddu, R., Drago, F., Malaguarnera, M. Folate levels in hepatocellular carcinoma patients with portal vein thrombosis
(2020) BMC Gastroenterology, 20 (1), art. no. 375, IF 3.067.
505. Romano, G.L., Platania, C.B.M., Leggio, G.M., Torrisi, S.A., Giunta, S., Salomone, S., Purrello, M., Ragusa, M., Barbagallo, C., Giblin, F.J., Mastrogiacomo, R., Managò, F., Cammalleri, M., Papaleo, F., Drago, F., Bucolo, C. Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 (2020) Scientific Reports, 10 (1), art. no. 3972, IF 4.380.
504. Gozzo, L., Longo, L., Vitale, D.C., Drago, F. Dexamethasone Treatment for Covid-19, a Curious Precedent Highlighting a Regulatory Gap (2020) Frontiers in Pharmacology, 11, art. no. 621934, IF 5.811.
503. Lopes, N., Vernuccio, F., Costantino, C., Imburgia, C., Gregoretti, C., Salomone, S., Drago, F., Lo Bianco, G. An Italian Guidance Model for the Management of Suspected or Confirmed COVID-19 Patients in the Primary Care Setting (2020) Frontiers in Public Health, 8, art. no. 572042, IF 3.709.
502. Torrisi, S.A., Laudani, S., Contarini, G., De Luca, A., Geraci, F., Managò, F., Papaleo, F., Salomone, S., Drago, F., Leggio, G.M. Dopamine, cognitive impairments and second-generation antipsychotics: From mechanistic advances to more personalized treatments (2020) Pharmaceuticals, 13 (11), art. no. 365, pp. 1-14, IF 5.863.
501. Sciacca, G., Mostile, G., Nicoletti, A., Salomone, S., Drago, F., Zappia, M. Cut-off scores of blink reflex recovery cycle to differentiate atypical parkinsonisms (2020) European Journal of Neurology, 27 (11), p. e68, IF 6.089.
500. Schmitz, F., Guo, K., Horn, J., Sorrentino, R., Conforto, G., Lamberti, F., Brescia, R., Drago, F., Prato, M., He, Z., Giovanella, U., Cacialli, F., Schlettwein, D., Meggiolaro, D., Gatti, T. Lanthanide-Induced Photoluminescence in Lead-Free Cs2AgBiBr6Bulk Perovskite: Insights from Optical and Theoretical Investigations (2020) Journal of Physical Chemistry Letters, 11 (20), pp. 8893-8900, IF 6.475.
499. Giurdanella, G., Lupo, G., Gennuso, F., Conti, F., Furno, D.L., Mannino, G., Anfuso, C.D., Drago, F., Salomone, S., Bucolo, C. Activation of the VEGF-A/ERK/PLA2 axis mediates early retinal endothelial cell damage induced by high glucose: New insight from an in vitro model of diabetic retinopathy (2020) International Journal of Molecular Sciences, 21 (20), art. no. 7528, pp. 1-19, IF 5.924.
498. Mannino, G., Gennuso, F., Giurdanella, G., Conti, F., Drago, F., Salomone, S., Furno, D.L., Bucolo, C., Giuffrida, R. Pericyte-like differentiation of human adipose-derived mesenchymal stem cells: An in vitro study (2020) World Journal of Stem Cells, 12 (10), pp. 1152-1170, IF 5.326.
497. Romano, G.L., Amato, R., Lazzara, F., Porciatti, V., Chou, T.-H., Drago, F., Bucolo, C.
P2X7 receptor antagonism preserves retinal ganglion cells in glaucomatous mice (2020) Biochemical Pharmacology, 180, art. no. 114199, IF 5.858.
496. Giuliano, L., Mainieri, G., Cicero, C.E., Battaglia, G., Guccione, A., Salomone, S., Drago, F., Nicoletti, A., Sofia, V., Zappia, M. Parasomnias, sleep-related movement disorders and physiological sleep variants in focal epilepsy: A polysomnographic study (2020) Seizure, 81, pp. 84-90, IF 3.184.
495. Gozzo, L., Longo, L., Vitale, D.C., Drago, F. The Regulatory Challenges for Drug Repurposing During the Covid-19 Pandemic: The Italian Experience (2020) Frontiers in Pharmacology, 11, art. no. 588132 IF 5.811.
494. Drago, F., Gozzo, L., Li, L., Stella, A., Cosmi, B. Use of Enoxaparin to Counteract COVID-19 Infection and Reduce Thromboembolic Venous Complications: A Review of the Current Evidence
(2020) Frontiers in Pharmacology, 11, art. no. 579886, IF 5.811.
493. Gozzo, L., Viale, P., Longo, L., Vitale, D.C., Drago, F. The Potential Role of Heparin in Patients With COVID-19: Beyond the Anticoagulant Effect. A Review (2020) Frontiers in Pharmacology, 11, art. no. 1307, IF 5.811.
492. Zeng, J., Rino, T., Bejtka, K., Castellino, M., Sacco, A., Farkhondehfal, M.A., Chiodoni, A., Drago, F., Pirri, C.F. Coupled Copper–Zinc Catalysts for Electrochemical Reduction of Carbon Dioxide (2020) ChemSusChem, 13 (16), pp. 4128-4139, IF 8.928.
491. Oliveira da Cruz, J.F., Busquets-Garcia, A., Zhao, Z., Varilh, M., Lavanco, G., Bellocchio, L., Robin, L., Cannich, A., Julio-Kalajzić, F., Lesté-Lasserre, T., Maître, M., Drago, F., Marsicano, G., Soria-Gómez, E. Specific Hippocampal Interneurons Shape Consolidation of Recognition Memory
(2020) Cell Reports, 32 (7), art. no. 108046, IF 9.423.
490. Platania, C.B.M., Ronchetti, S., Riccardi, C., Migliorati, G., Marchetti, M.C., Di Paola, L., Lazzara, F., Drago, F., Salomone, S., Bucolo, C. Effects of protein-protein interface disruptors at the ligand of the glucocorticoid-induced tumor necrosis factor receptor-related gene (GITR) (2020) Biochemical Pharmacology, 178, art. no. 114110, IF 5.858.
489. Lazzara, F., Trotta, M.C., Platania, C.B.M., D’Amico, M., Petrillo, F., Galdiero, M., Gesualdo, C., Rossi, S., Drago, F., Bucolo, C. Stabilization of HIF-1α in Human Retinal Endothelial Cells Modulates Expression of miRNAs and Proangiogenic Growth Factors
(2020) Frontiers in Pharmacology, 11, art. no. 1063, IF 5.811.
488. Stark, T., Di Bartolomeo, M., Di Marco, R., Drazanova, E., Platania, C.B.M., Iannotti, F.A., Ruda-Kucerova, J., D’Addario, C., Kratka, L., Pekarik, V., Piscitelli, F., Babinska, Z., Fedotova, J., Giurdanella, G., Salomone, S., Sulcova, A., Bucolo, C., Wotjak, C.T., Starcuk, Z., Jr, Drago, F., Mechoulam, R., Di Marzo, V., Micale, V. Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment (2020) Biochemical Pharmacology, 177, art. no. 114004, IF 5.858.
487. De Pasquale, D., Marino, A., Tapeinos, C., Pucci, C., Rocchiccioli, S., Michelucci, E., Finamore, F., McDonnell, L., Scarpellini, A., Lauciello, S., Prato, M., Larrañaga, A., Drago, F., Ciofani, G.
Homotypic targeting and drug delivery in glioblastoma cells through cell membrane-coated boron nitride nanotubes (2020) Materials and Design, 192, art. no. 108742, IF 7.991.
486. Sciacca, G., Mostile, G., Disilvestro, I., Donzuso, G., Manna, R., Portaro, G., Rascunà, C., Salomone, S., Drago, F., Nicoletti, A., Zappia, M. Asymmetry index of Blink Reflex Recovery Cycle differentiates Parkinson’s disease from atypical Parkinsonian syndromes (2020) Journal of Neurology, 267 (6), pp. 1859-1863, IF 4.849.
485. Trifirò G, Crisafulli S, Andò G, Racagni G, Drago F; Italian Society of Pharmacology. Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? Drug Saf. 2020 Apr 17, IF 5.606.
484. Carta MG, Fineberg N, Moro MF, Preti A, Romano F, Balestrieri M, Caraci F, Dell’Osso L, Disciascio G, Drago F, Hardoy MC, Roncone R, Minerba L, Faravelli C, Angst J. The Burden of Comorbidity Between Bipolar Spectrum and Obsessive-Compulsive Disorder in an Italian Community Survey. Front Psychiatry. 2020 Mar 31;11:188, IF 4.157.
483. Castellano S, Torrent C, Petralia MC, Godos J, Cantarella RA, Ventimiglia A., De Vivo S, Platania S, Guarnera M, Pirrone C, Drago F, Vieta E, Di Nuovo S, Popovic D, Caraci F. Clinical and Neurocognitive Predictors of Functional Outcome in Depressed Patients with Partial Response to Treatment: One Year Follow-Up Study. Neuropsychiatr Dis Treat. 2020 Feb 28;16:589-595, IF 2.570.
482. Platania CBM, Pittalà V, Pascale A, Marchesi N, Anfuso CD, Lupo G, Cristaldi M., Olivieri M, Lazzara F, Di Paola L, Drago F, Bucolo C. Novel indole derivatives targeting HuR-mRNA complex to counteract high glucose damage in retinal endothelial cells. Biochem Pharmacol. 2020 Mar 19; 175:113908, IF 5.858.
481. Romano GL, Platania CBM, Leggio GM, Torrisi SA, Giunta S, Salomone S, Purrello M, Ragusa M, Barbagallo C, Giblin FJ, Mastrogiacomo R, Managò F, Cammalleri M, Papaleo F, Drago F, Bucolo C. Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7. Sci Rep. 2020 Mar 4;10(1):3972, IF 4.380.
480. Fresta CG, Fidilio A, Caruso G, Caraci F, Giblin FJ, Leggio GM, Salomone S, Drago F, Bucolo C. A New Human Blood-Retinal Barrier Model Based on Endothelial Cells, Pericytes, and Astrocytes. Int J Mol Sci. 2020 Feb 27;21(5). pii: E1636, IF 5.924.
479. Puglia C, Santonocito D, Ostacolo C, Maria Sommella E, Campiglia P, Carbone C, Drago F, Pignatello R, Bucolo C. Ocular Formulation Based on Palmitoylethanolamide-Loaded Nanostructured Lipid Carriers: Technological and Pharmacological Profile. Nanomaterials (Basel). 2020 Feb 8;10(2). pii: E287, IF 5.076.
478. Boulkrane MS, Fedotova J, Kolodyaznaya V, Micale V, Drago F, van den Tol AJM, Baranenko D. Vitamin D and Depression in Women: A Mini-review. Curr Neuropharmacol. 2020;18(4):288-300, IF 7.390.
477. Bucolo C, Fidilio A, Fresta CG, Lazzara F, Platania CBM, Cantarella G, Di Benedetto G, Burgaletto C, Bernardini R, Piazza C, Barabino S, Drago F. OcularPharmacological Profile of Hydrocortisone in Dry Eye Disease. Front Pharmacol. 2019 Oct 18;10:1240. doi: 10.3389/fphar.2019.01240, IF 4.225.
476. Sipeky C, Llerena A, Manolopoulos VG, Pearson E, Mlakar V, Gozzo L, Simmaco M, Marchetti P, Re MD, Stankovic S, Meyer U, Cascorbi I, Ingelman-Sundberg M, Suarez-Kurtz G, Marc J, Katsila T, Paulmichl M, Nofziger C, Ansari M, Drago F, van Schaik RH. 4th ESPT Conference: pharmacogenomics and personalized medicine – research progress and clinical implementation. Pharmacogenomics. 2019 Oct;20(15):1063-1069, IF 2.339.
475. Caraci F, Merlo S, Drago F, Caruso G, Parenti C, Sortino MA. Rescue of Noradrenergic System as a Novel Pharmacological Strategy in the Treatment of Chronic Pain: Focus on Microglia Activation. Front Pharmacol. 2019 Sep 12;10:1024, IF 4.225.
474. Caruso G, Fresta CG, Fidilio A, O’Donnell F, Musso N, Lazzarino G, Grasso M, Amorini AM, Tascedda F, Bucolo C, Drago F, Tavazzi B, Lazzarino G, Lunte SM, Caraci F. Carnosine Decreases PMA-Induced Oxidative Stress and Inflammation in Murine Macrophages. Antioxidants (Basel). 2019 Aug 6;8(8). pii: E281, IF 5.014.
473. Koshkina A, Dudnichenko T, Baranenko D, Fedotova J, Drago F. Effects of Vitamin D(3) in Long-Term Ovariectomized Rats Subjected to Chronic Unpredictable Mild Stress: BDNF, NT-3, and NT-4 Implications. Nutrients. 2019 Jul 26;11(8). pii: E1726, IF 4.546.
472. Lazzara F, Fidilio A, Platania CBM, Giurdanella G, Salomone S, Leggio GM, Tarallo V, Cicatiello V, De Falco S, Eandi CM, Drago F, Bucolo C. Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway. Biochem Pharmacol. 2019 Oct;168:341-351, IF 4.960.
471. Pannuzzo G, Graziano ACE, Avola R, Drago F, Cardile V. Screening for Krabbe disease: The first 2 years’ experience. Acta Neurol Scand. 2019 Nov;140(5):359-365, IF 2.684.
470. Platania CBM, Lazzara F, Fidilio A, Fresta CG, Conti F, Giurdanella G, Leggio GM, Salomone S, Drago F, Bucolo C. Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor. Biochem Pharmacol. 2019 Oct;168:249-258, IF 4.960.
469. Bucolo C, Leggio GM, Drago F, Salomone S. Dopamine outside the brain: The eye, cardiovascular system and endocrine pancreas. Pharmacol Ther. 2019 Nov;203:107392, IF 10.557.
468. Torrisi SA, Geraci F, Tropea MR, Grasso M, Caruso G, Fidilio A, Musso N, Sanfilippo G, Tascedda F, Palmeri A, Salomone S, Drago F, Puzzo D, Leggio GM, Caraci F. Fluoxetine and Vortioxetine Reverse Depressive-Like Phenotype and Memory Deficits Induced by Aβ(1-42) Oligomers in Mice: A Key Role of Transforming Growth Factor-β1. Front Pharmacol. 2019 Jun 21;10:693, IF 4.225.
467. Latteri S, Malaguarnera G, Catania VE, La Greca G, Bertino G, Borzì AM, Drago F, Malaguarnera M. Homocysteine Serum Levels as Prognostic Marker of Hepatocellular Carcinoma with Portal Vein Thrombosis. Curr Mol Med. 2019;19(7):532-538, 1.600.
466. Leggio GM, Di Marco R, Gulisano W, D’Ascenzo M, Torrisi SA, Geraci F, Lavanco G, Dahl K, Giurdanella G, Castorina A, Aitta-Aho T, Aceto G, Bucolo C, Puzzo D, Grassi C, Korpi ER, Drago F, Salomone S. Dopaminergic-GABAergic interplay and alcohol binge drinking. (2019) Pharmacol Res., 141:384-391, IF 5.893.
465. Torrisi SA, Leggio GM, Drago F, Salomone S. Therapeutic Challenges of Post-traumatic Stress Disorder: Focus on the Dopaminergic System. (2019) Front Pharmacol, 10:404, IF 4.225.
464. Caruso G, Fresta CG, Musso N, Giambirtone M, Grasso M, Spampinato SF, Merlo S, Drago F, Lazzarino G, Sortino MA, Lunte SM, Caraci F.Carnosine Prevents Aβ-Induced Oxidative Stress and Inflammation in Microglial Cells: A Key Role of TGF-β1. (2019) Cells, 8(1), IF 4.366.
463. D’Amico AG, Maugeri G, Rasà D, Federico C, Saccone S, Lazzara F, Fidilio A, Drago F, Bucolo C, D’Agata V. NAP modulates hyperglycemic-inflammatory event of diabetic retina by counteracting outer blood retinal barrier damage. (2019) J Cell Physiol, 234(4):5230-5240, IF 5.546.
462. Stark T, Ruda-Kucerova J, Iannotti FA, D’Addario C, Di Marco R, Pekarik V, Drazanova E, Piscitelli F, Bari M, Babinska Z, Giurdanella G, Di Bartolomeo M, Salomone S, Sulcova A, Maccarrone M, Wotjak CT, Starcuk Z Jr, Drago F, Mechoulam R, Di Marzo V, Micale V. Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia. (2019) Neuropharmacology, 146:212-221, IF 4.431
461. Castrogiovanni P, Di Rosa M, Ravalli S, Castorina A, Guglielmino C, Imbesi R, Vecchio M, Drago F, Szychlinska MA, Musumeci G. Moderate Physical Activity as a Prevention Method for Knee Osteoarthritis and the Role of Synoviocytes as Biological Key. (2019) Int J Mol Sci, 20(3), IF 4.556 .
460. Drazanova E, Ruda-Kucerova J, Kratka L, Stark T, Kuchar M, Maryska M, Drago F, Starcuk Z Jr, Micale V. Different effects of prenatal MAM vs. perinatal THC exposure on regional cerebral blood perfusion detected by Arterial Spin Labelling MRI in rats. Sci Rep, 9(1):6062, IF 3.998.
459. Micale V, Drago F, Noerregaard PK, Elling CE, Wotjak CT. The Cannabinoid CB1 Antagonist TM38837 With Limited Penetrance to the Brain Shows Reduced Fear-Promoting Effects in Mice. (2019) Front Pharmacol, 10:207, IF 4.225.
458. Platania CBM, Dei Cas M, Cianciolo S, Fidilio A, Lazzara F, Paroni R, Pignatello R, Strettoi E, Ghidoni R, Drago F, Bucolo C. Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa. (2019) Drug Deliv, 26(1):237-243, IF 4.902 .
457. Platania CBM, Maisto R, Trotta MC, D’Amico M, Rossi S, Gesualdo C, D’Amico G, Balta C, Herman H, Hermenean A, Ferraraccio F, Panarese I, Drago F, Bucolo C. Retinal and circulating miRNA expression patterns in diabetic retinopathy: An in silico and in vivo approach. (2019) Br J Pharmacol. doi: 10.1111/bph.14665, IF 7.730.
456. Bucolo C, Drago F, Maisto R, Romano GL, D’Agata V, Maugeri G, Giunta S. Curcumin prevents high glucose damage in retinal pigment epithelial cells through ERK1/2-mediated activation of the Nrf2/HO-1 pathway. (2019) J Cell Physiol. doi: 10.1002/jcp.28347, IF 5.546.
455. Sancassiani F, Carmassi C, Romano F, Balestrieri M, Caraci F, Di Sciascio G, Drago F, Faravelli C, Hardoy MC, Moro MF, Roncone R, Preti A, Dell’Osso L. Impairment of Quality of Life Associated With Lifetime Diagnosis of Post-traumatic Stress Disorder in Women – A National Survey in Italy. (2019) Clin Pract Epidemiol Ment Health, 15:38-43, IF 0.442.
454. Sancassiani F, Romano F, Balestrieri M, Caraci F, Di Sciascio G, Drago F, Hardoy MC, Moro MF, Roncone R, Piras M, Preti A, Dell’Osso L, Faravelli C, Carta MG. The Prevalence of Specific Phobia by Age in an Italian Nationwide Survey: How Much Does it Affect the Quality of Life? (2019) Clin Pract Epidemiol Ment Health,15:30-37, IF 0.442.
453. Giurdanella G, Montalbano G, Gennuso F, Brancati S, Lo Furno D, Augello A, Bucolo C, Drago F, Salomone S. Isolation, cultivation, and characterization of primary bovine cochlear pericytes: A new in vitro model of stria vascularis. (2019) J Cell Physiol. 234(3):1978-1986, IF 5.546.
452. Bucolo C, Gozzo L, Longo L, Mansueto S, Vitale DC, Drago F. Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies..(2018) J Pharmacol Sci. 138(4):219-232, IF 2.439.
451. Sciacca G, Nicoletti A, Mostile G, Luca A, Raciti L, Dibilio V, Drago F, Salomone S, Zappia M. Blink reflex recovery cycle to differentiate progressive supranuclear palsy from corticobasal syndrome. (2018) Eur J Neurol, 25(8):1100-e85, IF 4.387.
450. Caraci, F., Calabrese, F., Molteni, R., Bartova, L., Dold, M., Leggio, G.M., Fabbri, C., Mendlewicz, J., Racagni, G., Kasper, S., Riva, M.A., Drago, F. International union of basic and clinical pharmacology CIV: The neurobiology of treatment-resistant depression: From antidepressant classifications to novel pharmacological targets (2018) Pharmacological Reviews, 70 (3), pp. 475-504, IF 18.886.
449. Pratico AD, Longo L, Mansueto S, Gozzo L, Barberi I, Tiralongo V, Salvo V, Falsaperla R, Vitaliti G, La Rosa M, Leonardi S, Rotondo A, Avola N, Sgarlata D, Damiano A, Tirantello M, Anzelmo G, Cipolla D, Rizzo A, Russo A, Ruggieri M, Salomone S, Drago F. Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study. (2018) Curr Drug Saf.;13(3):200-207, IF 3.526.
448. Bucolo C, Platania CBM, Drago F, Bonfiglio V, Reibaldi M, Avitabile T, Uva M. Novel Therapeutics in Glaucoma Management (2018) Curr Neuropharmacol. 2018;16(7):978-992, IF 4.568.
447. Micale V, Drago F. Endocannabinoid system, stress and HPA axis. (2018) Eur JPharmacol. 2018 Sep 5;834:230-239. doi: 10.1016/j.ejphar.2018.07.039, IF 3.170.
446. Busquets-Garcia A, Oliveira da Cruz JF, Terral G, Zottola ACP, Soria-Gómez E, Contini A, Martin H, Redon B, Varilh M, Ioannidou C, Drago F, Massa F, Fioramonti X, Trifilieff P, Ferreira G, Marsicano G. Hippocampal CB(1) Receptors Control Incidental Associations. (2018) Neuron. Sep 19;99(6):1247-1259.e7, IF 14.403.
445. Platania CBM, Leggio GM, Drago F, Salomone S, Bucolo C. Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy. (2018) Biochem Pharmacol. Sep 15; 158:13-26, 4.825.
444. Malaguarnera M, Latteri S, Bertino G, Madeddu R, Catania VE, Currò G, Borzì AM, Drago F, Malaguarnera G. D-dimer plasmatic levels as a marker for diagnosis and prognosis of hepatocellular carcinoma patients with portal vein thrombosis. (2018) Clin Exp Gastroenterol. 2018 Oct 3; 11:373-380. doi: 10.2147/CEG.S172663. eCollection 2018, IF 3.083 .
443. D’Amico AG, Maugeri G, Rasà D, Federico C, Saccone S, Lazzara F, Fidilio A, Drago F, Bucolo C, D’Agata V. NAP modulates hyperglycemic-inflammatory event of diabetic retina by counteracting outer blood retinal barrier damage. (2018) J Cell Physiol. 2018 Oct 30. doi: 10.1002/jcp.27331, IF 4.522.
442. Platania, C.B.M., Fidilio, A., Lazzara, F., Piazza, C., Geraci, F., Giurdanella, G., Leggio, G.M., Salomone, S., Drago, F., Bucolo, C. Retinal protection and distribution of curcumin in vitro and in vivo (2018) Frontiers in Pharmacology, 9 (JUN), IF 3.845.
441. Robin, L.M., Oliveira da Cruz, J.F., Langlais, V.C., Martin-Fernandez, M., Metna-Laurent, M., Busquets-Garcia, A., Bellocchio, L., Soria-Gomez, E., Papouin, T., Varilh, M., Sherwood, M.W., Belluomo, I., Balcells, G., Matias, I., Bosier, B., Drago, F., Van Eeckhaut, A., Smolders, I., Georges, F., Araque, A., Panatier, A., Oliet, S.H.R., Marsicano, G. Astroglial CB1 Receptors Determine Synaptic D-Serine Availability to Enable Recognition Memory (2018) Neuron, 98 (5), pp. 935-944.e5, IF 14.403.
440. Musumeci, G., Leggio, G.M., Marzagalli, R., Al-Badri, G., Drago, F., Castorina, A. Identification of dysregulated microRNA networks in schwann cell-like cultures exposed to immune challenge: Potential crosstalk with the protective VIP/PACAP neuropeptide system (2018) International Journal of Molecular Sciences, 19 (4), IF 4.183.
439. Caraci, F., Spampinato, S.F., Morgese, M.G., Tascedda, F., Salluzzo, M.G., Giambirtone, M.C., Caruso, G., Munafò, A., Torrisi, S.A., Leggio, G.M., Trabace, L., Nicoletti, F., Drago, F., Sortino, M.A., Copani, A. Neurobiological links between depression and AD: The role of TGF-β1 signaling as a new pharmacological target (2018) Pharmacological Research, 130, pp. 374-384, IF 5.574.
438. Puglia, C., Blasi, P., Ostacolo, C., Sommella, E., Bucolo, C., Platania, C.B., Romano, G.L., Geraci, F., Drago, F., Santonocito, D., Albertini, B., Campiglia, P., Puglisi, G., Pignatello, R. Innovative nanoparticles enhance N-palmitoylethanolamide intraocular delivery (2018) Frontiers in Pharmacology, 9 (MAR), IF 3.845.
437. Malaguarnera, G., Pennisi, M., Bertino, G., Motta, M., Borzì, A.M., Vicari, E., Bella, R., Drago, F., Malaguarnera, M. Resveratrol in patients with minimal hepatic encephalopathy (2018) Nutrients, 10 (3), IF 4.171.
436. Sciacca, G., Reggio, E., Mostile, G., Nicoletti, A., Drago, F., Salomone, S., Zappia, M. Clinical and CN-SFEMG evaluation of neostigmine test in myasthenia gravis (2018) Neurological Sciences, 39 (2), pp. 341-345, IF 2.484.
435. Bucolo, C., Fidilio, A., Platania, C.B.M., Geraci, F., Lazzara, F., Drago, F. Antioxidant and osmoprotecting activity of taurine in dry eye models (2018) Journal of Ocular Pharmacology and Therapeutics, 34 (1-2), pp. 188-194, IF 1.792.
434. Al-Badri, G., Leggio, G.M., Musumeci, G., Marzagalli, R., Drago, F., Castorina, A. Tackling dipeptidyl peptidase IV in neurological disorders (2018) Neural Regeneration Research, 13 (1), pp. 26-34, IF 2.472.
433. Malaguarnera, G., Madeddu, R., Catania, V.E., Bertino, G., Morelli, L., Perrotta, R.E., Drago, F., Malaguarnera, M., Latteri, S. Anorectal mucosal melanoma (2018) Oncotarget, 9 (9), pp. 8785-8800, IF 3.673.
432. Caraci, F., Iulita, M.F., Pentz, R., Flores Aguilar, L., Orciani, C., Barone, C., Romano, C., Drago, F., Cuello, A.C. Searching for new pharmacological targets for the treatment of Alzheimer’s disease in Down syndrome (2017) European Journal of Pharmacology, 817, pp. 7-19, IF 3.040.
431. Aloisi, E., Le Corf, K., Dupuis, J., Zhang, P., Ginger, M., Labrousse, V., Spatuzza, M., Georg Haberl, M., Costa, L., Shigemoto, R., Tappe-Theodor, A., Drago, F., Vincenzo Piazza, P., Mulle, C., Groc, L., Ciranna, L., Catania, M.V., Frick, A. Altered surface mGluR5 dynamics provoke synaptic NMDAR dysfunction and cognitive defects in Fmr1 knockout mice (2017) Nature Communications, 8 (1), art. no. 1103, IF 12.353.
430. Gozzo, L., Navarria, A., Benfatto, G., Longo, L., Mansueto, S., Sottosanti, L., Pani, L., Salomone, S., Drago, F. Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network (2017) Clinical Drug Investigation, 37 (11), pp. 1067-1081, IF 1.918.
429. Giurdanella, G., Lazzara, F., Caporarello, N., Lupo, G., Anfuso, C.D., Eandi, C.M., Leggio, G.M., Drago, F., Bucolo, C., Salomone, S. Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE (2017) Biochemical Pharmacology, 142, pp. 145-154, IF 4.235.
428. Torrisi, S.A., Salomone, S., Geraci, F., Caraci, F., Bucolo, C., Drago, F., Leggio, G.M. Buspirone counteracts MK-801-induced schizophrenia-like phenotypes through dopamine D3 receptor blockade (2017) Frontiers in Pharmacology, 8 (OCT), art. no. 710, IF 3.831.
427. D’Addario, C., Micale, V., Di Bartolomeo, M., Stark, T., Pucci, M., Sulcova, A., Palazzo, M., Babinska, Z., Cremaschi, L., Drago, F., Carlo Altamura, A., Maccarrone, M., Dell’Osso, B. A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia (2017) Schizophrenia Research, 188, pp. 132-140, IF 3.958.
426. Platania, C.B.M., Fisichella, V., Fidilio, A., Geraci, F., Lazzara, F., Leggio, G.M., Salomone, S., Drago, F., Pignatello, R., Caraci, F., Bucolo, C. Topical ocular delivery of TGF-β1 to the back of the eye: Implications in age-related neurodegenerative diseases (2017) International Journal of Molecular Sciences, 18 (10), art. no. 2076, IF 3.687 .
425. Pennisi, M., Bertino, G., Gagliano, C., Malaguarnera, M., Bella, R., Borzì, A.M., Madeddu, R., Drago, F., Malaguarnera, G. Resveratrol in hepatitis C patients treated with pegylated-interferon-α-2b and ribavirin reduces sleep disturbance (2017) Nutrients, 9 (8), art. no. 897, IF 4.196.
424. Platania, C.B.M., Giurdanella, G., Di Paola, L., Leggio, G.M., Drago, F., Salomone, S., Bucolo, C. P2X7 receptor antagonism: Implications in diabetic retinopathy (2017) Biochemical Pharmacology, 138, pp. 130-139, IF 4.235.
423. Villari, A., Giurdanella, G., Bucolo, C., Drago, F., Salomone, S. Apixaban enhances vasodilatation mediated by protease-activated receptor 2 in isolated rat arteries (2017) Frontiers in Pharmacology, 8 (JUL), art. no. 480, IF 3.831.
422. Micale, V., Stepan, J., Jurik, A., Pamplona, F.A., Marsch, R., Drago, F., Eder, M., Wotjak, C.T. Extinction of avoidance behavior by safety learning depends on endocannabinoid signaling in the hippocampus (2017) Journal of Psychiatric Research, 90, pp. 46-59, IF 4.000.
421. Sortino, M.A., Salomone, S., Carruba, M.O., Drago, F. Polycystic ovary syndrome: Insights into the therapeutic approach with inositols (2017) Frontiers in Pharmacology, 8 (JUN), art. no. 341, IF 3.831
420. Devroye, C., Haddjeri, N., Cathala, A., Rovera, R., Drago, F., Piazza, P.V., Artigas, F., Spampinato, U. Opposite control of mesocortical and mesoaccumbal dopamine pathways by serotonin2B receptor blockade: Involvement of medial prefrontal cortex serotonin1A receptors (2017) Neuropharmacology, 119, pp. 91-99, IF 4.249.
419. Caraci, F., Sultana, J., Drago, F., Spina, E. Clinically relevant drug interactions with anti-Alzheimer’s drugs (2017) CNS and Neurological Disorders – Drug Targets, 16 (4), pp. 501-513, IF 2.084.
418. Anfuso, C.D., Olivieri, M., Fidilio, A., Lupo, G., Rusciano, D., Pezzino, S., Gagliano, C., Drago, F., Bucolo, C. Gabapentin attenuates ocular inflammation: In vitro and in vivo studies (2017) Frontiers in Pharmacology, 8, art. no. 173, IF 3.831.
417. Romano, G.L., Platania, C.B., Drago, F., Salomone, S., Ragusa, M., Barbagallo, C., Pietro, C.D., Purrello, M., Reibaldi, M., Avitabile, T., Longo, A., Bucolo, C. Retinal and circulating miRNAs in age-related macular degeneration: An in vivo animal and human study (2017) Frontiers in Pharmacology, 8 (MAR), art. no. 168, IF 3.831.
416. Ruda-Kucerova, J., Babinska, Z., Amchova, P., Stark, T., Drago, F., Sulcova, A., Micale, V. Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats (2017) World Journal of Biological Psychiatry, 18 (2), pp. 129-142, IF 3.713.
415. Malaguarnera, G., Catania, V.E., Francaviglia, A., Malaguarnera, M., Drago, F., Motta, M., Latteri, S. Lipoprotein(a) in patients with hepatocellular carcinoma and portal vein thrombosis (2017) Aging Clinical and Experimental Research, 29 (1), pp. 185-190, IF 2.121.
414. Caraci, F., Leggio, G.M., Salomone, S., Drago, F. New drugs in psychiatry: Focus on new pharmacological targets (2017) F1000Research, 6, art. no. 397, IF 2.127.
413. Androvicova, R., Horacek, J., Stark, T., Drago, F., Micale, V. Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon? (2017) Pharmacological Research, 115, pp. 200-208, IF 4.897.
412. Nutt, D., Stahl, S., Blier, P., Drago, F., Zohar, J., Wilson, S. Inverse agonists – What do they mean for psychiatry? (2017) European Neuropsychopharmacology, 27 (1), pp. 87-90, IF 4.129.
411. Pittalà, V., Fidilio, A., Lazzara, F., Platania, C.B.M., Salerno, L., Foresti, R., Drago, F., Bucolo, C. Effects of Novel Nitric Oxide-Releasing Molecules against Oxidative Stress on Retinal Pigmented Epithelial Cells (2017) Oxidative Medicine and Cellular Longevity, 2017, art. no. 1420892, IF 4.936.
410. Caraci, F., Enna, S.J., Zohar, J., Racagni, G., Zalsman, G., van den Brink, W., Kasper, S., Koob, G.F., Pariante, C.M., Piazza, P.V., Yamada, K., Spedding, M., Drago, F. A new nomenclature for classifying psychotropic drugs (2017) British Journal of Clinical Pharmacology, 83 (8), pp. 1614-1616, IF 3.838.
409. Castellano, S., Ventimiglia, A., Salomone, S., Ventimiglia, A., de Vivo, S., Signorelli, M.S., Bellelli, E., Santagati, M., Cantarella, R.A., Fazio, E., Aguglia, E., Drago, F., Di Nuovo, S., Caraci, F. Selective serotonin reuptake inhibitors and serotonin and noradrenaline reuptake inhibitors improve cognitive function in partial responders depressed patients: Results from a prospective observational cohort study (2016) CNS and Neurological Disorders – Drug Targets, 15 (10), pp. 1290-1298, IF 2.506.
408. Hebert-Chatelain, E., Desprez, T., Serrat, R., Bellocchio, L., Soria-Gomez, E., Busquets-Garcia, A., Pagano Zottola, A.C., Delamarre, A., Cannich, A., Vincent, P., Varilh, M., Robin, L.M., Terral, G., García-Fernández, M.D., Colavita, M., Mazier, W., Drago, F., Puente, N., Reguero, L., Elezgarai, I., Dupuy, J.-W., Cota, D., Lopez-Rodriguez, M.-L., Barreda-Gómez, G., Massa, F., Grandes, P., Bénard, G., Marsicano, G. A cannabinoid link between mitochondria and memory (2016) Nature, 539 (7630), pp. 555-559, IF 40.137.
407. Malaguarnera, G., Bertino, G., Chisari, G., Motta, M., Vecchio, M., Vacante, M., Caraci, F., Greco, C., Drago, F., Nunnari, G., Malaguarnera, M. Silybin supplementation during HCV therapy with pegylated interferon-a plus ribavirin reduces depression and anxiety and increases work ability (2016) BMC Psychiatry, 16 (1), art. no. 398, IF 2.613.
406. Olivieri, M., Amata, E., Vinciguerra, S., Fiorito, J., Giurdanella, G., Drago, F., Caporarello, N., Prezzavento, O., Arena, E., Salerno, L., Rescifina, A., Lupo, G., Anfuso, C.D., Marrazzo, A. Antiangiogenic Effect of (±)-Haloperidol Metabolite II Valproate Ester [(±)-MRJF22] in Human Microvascular Retinal Endothelial Cells (2016) Journal of Medicinal Chemistry, 59 (21), pp. 9960-9966, IF 6.259.
405. Iulita, M.F., Ower, A., Barone, C., Pentz, R., Gubert, P., Romano, C., Cantarella, R.A., Elia, F., Buono, S., Recupero, M., Romano, C., Castellano, S., Bosco, P., Di Nuovo, S., Drago, F., Caraci, F., Cuello, A.C. An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: Relation to cognitive decline and longitudinal evaluation (2016) Alzheimer’s and Dementia, 12 (11), pp. 1132-1148, IF 4.385.
404. Caraci, F., Tascedda, F., Merlo, S., Benatti, C., Spampinato, S.F., Munaf�, A., Leggio, G.M., Nicoletti, F., Brunello, N., Drago, F., Sortino, M.A., Copani, A. Fluoxetine prevents Aβ1-42-induced toxicity via a paracrine signaling mediated by transforming-growth-factor-β1 (2016) Frontiers in Pharmacology, 7 (OCT), art. no. 389, IF 4.400.
403. Devroye, C., Cathala, A., Haddjeri, N., Rovera, R., Vallée, M., Drago, F., Piazza, P.V., Spampinato, U. Differential control of dopamine ascending pathways by serotonin2B receptor antagonists: New opportunities for the treatment of schizophrenia (2016) Neuropharmacology, 109, pp. 59-68, IF 5.012.
402. Leggio, G.M., Bucolo, C., Platania, C.B.M., Salomone, S., Drago, F. Current drug treatments targeting dopamine D3 receptor (2016) Pharmacology and Therapeutics, 165, pp. 164-177, IF 11.127.
401. Amadio, M., Pascale, A., Cupri, S., Pignatello, R., Osera, C., D’Agata, V., D’Amico, A.G., Leggio, G.M., Ruozi, B., Govoni, S., Drago, F., Bucolo, C. Nanosystems based on siRNA silencing HuR expression counteract diabetic retinopathy in rat (2016) Pharmacological Research, 111, pp. 713-720, IF 4.480.
400. Gozzo, L., Navarria, A., Drago, V., Longo, L., Mansueto, S., Pignataro, G., Cicchetti, A., Salomone, S., Drago, F. Linking the Price of Cancer Drug Treatments to Their Clinical Value (2016) Clinical Drug Investigation, 36 (7), pp. 579-589, IF 1.853.
399. Colavita, M., Terral, G., Lemercier, C.E., Drago, F., Marsicano, G., Massa, F. Layer-specific potentiation of network GABAergic inhibition in the CA1 area of the hippocampus (2016) Scientific Reports, 6, art. no. 28454, IF 4.259.
398. Navarria, A., Drago, V., Gozzo, L., Longo, L., Mansueto, S., Pignataro, G., Drago, F. Response to Letter to the Editor by Dr. Garattini (2016) Value in Health, 19 (4), p. 510, IF 4.235.
397. Oliveira da Cruz, J.F., Robin, L.M., Drago, F., Marsicano, G., Metna-Laurent, M. Astroglial type-1 cannabinoid receptor (CB1): A new player in the tripartite synapse (2016) Neuroscience, 323, pp. 35-42, IF 3.277.
396. Leggio, G.M., Catania, M.V., Puzzo, D., Spatuzza, M., Pellitteri, R., Gulisano, W., Torrisi, S.A., Giurdanella, G., Piazza, C., Impellizzeri, A.R., Gozzo, L., Navarria, A., Bucolo, C., Nicoletti, F., Palmeri, A., Salomone, S., Copani, A., Caraci, F., Drago, F. The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice (2016) Pharmacological Research, 106, pp. 10-20, IF 4.480.
395. Marzagalli, R., Leggio, G.M., Bucolo, C., Pricoco, E., Keay, K.A., Cardile, V., Castorina, S., Salomone, S., Drago, F., Castorina, A. Genetic blockade of the dopamine D3 receptor enhances hippocampal expression of PACAP and receptors and alters their cortical distribution (2016) Neuroscience, 316, pp. 279-295, IF 3.277.
394. Fisichella, V., Giurdanella, G., Platania, C.B.M., Romano, G.L., Leggio, G.M., Salomone, S., Drago, F., Caraci, F., Bucolo, C. TGF-β1 prevents rat retinal insult induced by amyloid-β (1–42) oligomers (2016) European Journal of Pharmacology, 787, pp. 72-77, IF 2.896.
393. D’Amico, A.G., Maugeri, G., Reitano, R., Bucolo, C., Saccone, S., Drago, F., D’Agata, V. PACAP Modulates Expression of Hypoxia-Inducible Factors in Streptozotocin-Induced Diabetic Rat Retina (2015) Journal of Molecular Neuroscience, 57 (4), pp. 501-509, IF 2.352.
392. Bucolo, C., Platania, C.B.M., Reibaldi, M., Bonfiglio, V., Longo, A., Salomone, S., Drago, F. Controversies in glaucoma: Current medical treatment and drug development (2015) Current Pharmaceutical Design, 21 (32), pp. 4673-4681, IF 3.052.
391. Devroye, C., Cathala, A., Di Marco, B., Caraci, F., Drago, F., Piazza, P.V., Spampinato, U. Central serotonin2B receptor blockade inhibits cocaine-induced hyperlocomotion independently of changes of subcortical dopamine outflow (2015) Neuropharmacology, 97, pp. 329-337, IF 4.936.
390. Navarria, A., Wohleb, E.S., Voleti, B., Ota, K.T., Dutheil, S., Lepack, A.E., Dwyer, J.M., Fuchikami, M., Becker, A., Drago, F., Duman, R.S. Rapid antidepressant actions of scopolamine: Role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors (2015) Neurobiology of Disease, 82, pp. 254-261, IF 4.856.
389. Drago, F. The dopamine D3 receptor: From preclinical studies to the treatment of psychiatric disorders (2015) European Neuropsychopharmacology, 25 (9), pp. 1399-1400, IF 4.409.
388. Carta, M.G., Norcini-Pala, A., Moro, M.F., Balestrieri, M., Caraci, F., Dell’Osso, L., Sciascio, G.D., Faravelli, C., Hardoy, M.C., Aguglia, E., Roncone, R., Nardi, A.E., Drago, F. Does Mood Disorder Questionnaire identify sub-threshold bipolarity? Evidence studying worsening of quality of life (2015) Journal of Affective Disorders, 183, art. no. 7435, pp. 173-178, IF 3.570.
387. Malaguarnera, G., Vacante, M., Drago, F., Bertino, G., Motta, M., Giordano, M., Malaguarnera, M. Endozepine-4 levels are increased in hepatic coma (2015) World Journal of Gastroenterology, 21 (30), pp. 9103-9110, IF 2.787.
386. Malaguarnera, G., Gagliano, C., Salomone, S., Giordano, M., Bucolo, C., Pappalardo, A., Drago, F., Caraci, F., Avitabile, T., Motta, M. Folate status in type 2 diabetic patients with and without retinopathy (2015) Clinical Ophthalmology, 9, pp. 1437-1442, IF 1.605.
385. D’Amico, A.G., Maugeri, G., Magro, G., Salvatorelli, L., Drago, F., D’Agata, V. Expression pattern of parkin isoforms in lung adenocarcinomas (2015) Tumor Biology, 36 (7), pp. 5133-5141, IF 2.926.
384. Foresti, R., Bucolo, C., Platania, C.M.B., Drago, F., Dubois-Randé, J.-L., Motterlini, R. Nrf2 activators modulate oxidative stress responses and bioenergetic profiles of human retinal epithelial cells cultured in normal or high glucose conditions (2015) Pharmacological Research, 99, art. no. 2868, pp. 296-307, IF 4.816.
383. Caraci, F., Pappalardo, G., Basile, L., Giuffrida, A., Copani, A., Tosto, R., Sinopoli, A., Giuffrida, M.L., Pirrone, E., Drago, F., Pignatello, R., Guccione, S. Neuroprotective effects of the monoamine oxidase inhibitor tranylcypromine and its amide derivatives against Aβ(1-42)-induced toxicity (2015) European Journal of Pharmacology, 764, art. no. 70113, pp. 256-263, IF 2.730.
382. Giurdanella, G., Anfuso, C.D., Olivieri, M., Lupo, G., Caporarello, N., Eandi, C.M., Drago, F., Bucolo, C., Salomone, S. Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway (2015) Biochemical Pharmacology, 96 (3), art. no. 12257, pp. 278-287, IF 5.091.
381. Caraci, F., Gulisano, W., Guida, C.A., Impellizzeri, A.A.R., Drago, F., Puzzo, D., Palmeri, A. A key role for TGF-β1 in hippocampal synaptic plasticity and memory (2015) Scientific Reports, 5, art. no. 11252, IF 5.228.
380. Scuderi, S., D’amico, A.G., Federico, C., Saccone, S., Magro, G., Bucolo, C., Drago, F., D’Agata, V. Different Retinal Expression Patterns of IL-1α, IL-1β, and Their Receptors in a Rat Model of Type 1 STZ-Induced Diabetes (2015) Journal of Molecular Neuroscience, 56 (2), pp. 431-439, IF 2.352.
379. Pittalà, V., Salerno, L., Romeo, G., Siracusa, M.A., Modica, M.N., Romano, G.L., Salomone, S., Drago, F., Bucolo, C. Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation (2015) European Journal of Pharmacology, 752, pp. 78-83, IF 2.730.
378. Castorina, A., Waschek, J.A., Marzagalli, R., Cardile, V., Drago, F. PACAP interacts with PAC1 receptors to induce tissue plasminogen activator (tPA) expression and activity in Schwann cell-like cultures (2015) PLoS ONE, 10 (2), art. no. e0117799, IF 3.057.
377. Leonardi, A., Bucolo, C., Drago, F., Salomone, S., Pignatello, R. Cationic solid lipid nanoparticles enhance ocular hypotensive effect of melatonin in rabbit (2015) International Journal of Pharmaceutics, 478 (1), pp. 180-186 IF 3.257, IF 3.994.
376. Micale, V., Tabiova, K., Kucerova, J., Drago, F. Role of the endocannabinoid system in depression: From preclinical to clinical evidence (2015) Cannabinoid Modulation of Emotion, Memory, and Motivation, pp. 97-129.
375. Marzagalli, R., Scuderi, S., Drago, F., Waschek, J.A., Castorina, A. Emerging role of PACAP as a new potential therapeutic target in major diabetes complications (2015) International Journal of Endocrinology, 2015, art. no. 160928, IF 2.376.
374. Navarria, A., Drago, V., Gozzo, L., Longo, L., Mansueto, S., Pignataro, G., Drago, F. Do the current performance-based schemes in Italy really work? “Success fee”: A novel measure for cost containment of drug expenditure (2015) Value in Health, 18 (1), pp. 131-136, IF 3.824.
373. Platania, C.B., Paola, L.D., Leggio, G.M., Romano, G.L., Drago, F., Salomone, S., Bucolo, C. Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: A computational approach (2015) Frontiers in Pharmacology, 6 (OCT), art. no. 237, IF 4.418.
372. Romano, G.L., Platania, C.B.M., Forte, S., Salomone, S., Drago, F., Bucolo, C. MicroRNA target prediction in glaucoma (2015) Progress in Brain Research, 220, pp. 217-240, IF 1.655.
371. Maugeri, G., D’Amico, A.G., Magro, G., Salvatorelli, L., Barbagall O, G.M.V., Saccone, S., Drago, F., Cavallaro, S., D’Agata, V. Expression profile of parkin isoforms in human gliomas (2015) International Journal of Oncology, 47 (4), pp. 1282-1292, 3.018.
370. Leggio, G.M., Torrisi, S.A., Castorina, A., Platania, C.B.M., Impellizzeri, A.A.R., Fidilio, A., Caraci, F., Bucolo, C., Drago, F., Salomone, S. Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam (2015) European Neuropsychopharmacology, 25 (9), pp. 1427-1436, IF 4.409.
369. Bucolo, C., Musumeci, M., Salomone, S., Romano, G.L., Leggio, G.M., Gagliano, C., Reibaldi, M., Avitabile, T., Uva, M.G., Musumeci, S., Drago, F. Effects of topical fucosyl-lactose, a milk oligosaccharide, on dry eye model: An example of nutraceutical candidate (2015) Frontiers in Pharmacology, 6 (NOV), art. no. 280, IF 4.418.
368. Carta, M.G., Moro, M.F., Aguglia, E., Balestrieri, M., Caraci, F., Dell’Osso, L., Di Sciascio, G., Drago, F., Hardoy, M.C., D’Aloja, E., Machado, S., Roncone, R., Faravelli, C. The attributable burden of panic disorder in the impairment of quality of life in a national survey in Italy (2015) International Journal of Social Psychiatry, 61 (7), pp. 693-699, IF 1.361.
367. Malaguarnera, M., Motta, M., Vacante, M., Malaguarnera, G., Caraci, F., Nunnari, G., Gagliano, C., Greco, C., Chisari, G., Drago, F., Bertino, G. Silybin-vitamin E-phospholipids complex reduces liver fibrosis in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin (2015) American Journal of Translational Research, 7 (11), pp. 2510-2518, IF 3.146.
366. Salomone, S., Foresti, R., Villari, A., Giurdanella, G., Drago, F., Bucolo, C. Regulation of vascular tone in rabbit ophthalmic artery: Cross talk of endogenous and exogenous gas mediators (2014) Biochemical Pharmacology, 92 (4), pp. 661-668, IF 5.009.
365. Scuderi, S., D’Amico, A.G., Castorina, A., Federico, C., Marrazzo, G., Drago, F., Bucolo, C., D’Agata, V. Davunetide (NAP) Protects the Retina Against Early Diabetic Injury by Reducing Apoptotic Death (2014) Journal of Molecular Neuroscience, 54 (3), pp. 395-404, IF 2.343.
364. Leonardi, A., Bucolo, C., Romano, G.L., Platania, C.B.M., Drago, F., Puglisi, G., Pignatello, R. Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles (2014) International Journal of Pharmaceutics, 470 (1-2), pp. 133-140, IF 3.650.
363. Scuderi, S., La Cognata, V., Drago, F., Cavallaro, S., D’Agata, V. Alternative splicing generates different parkin protein isoforms: Evidences in human, rat, and mouse brain (2014) BioMed Research International, 2014, art. no. 690796, IF 1.579.
362. Grosso, G., Biondi, A., Galvano, F., Mistretta, A., Marventano, S., Buscemi, S., Drago, F., Basile, F. Factors associated with colorectal cancer in the context of the mediterranean diet: A case control study (2014) Nutrition and Cancer, 66 (4), pp. 558-565, IF 2.322.
361. Grosso, G., Pajak, A., Marventano, S., Castellano, S., Galvano, F., Bucolo, C., Drago, F., Caraci, F. Role of omega-3 fatty acids in the treatment of depressive disorders: A comprehensive meta-analysis of randomized clinical trials (2014) PLoS ONE, 9 (5), art. no. e96905, IF 3.234.
360. Malaguarnera, G., Pennisi, M., Gagliano, C., Vacante, M., Malaguarnera, M., Salomone, S., Drago, F., Bertino, G., Caraci, F., Nunnari, G., Malaguarnera, M. Acetyl-L-carnitine supplementation during HCV therapy with pegylated interferon-α 2b plus ribavirin: Effect on work performance; a randomized clinical trial (2014) Hepatitis Monthly, 14 (5), IF 1.932.
359. Castorina, A., Scuderi, S., D’Amico, A.G., Drago, F., D’Agata, V. PACAP and VIP increase the expression of myelin-related proteins in rat schwannoma cells: Involvement of PAC1/VPAC2 receptor-mediated activation of PI3K/Akt signaling pathways (2014) Experimental Cell Research, 322 (1), pp. 108-121, IF 3.246.
358. Gagliano, C., Caruso, S., Napolitano, G., Malaguarnera, G., Cicinelli, M.V., Amato, R., Reibaldi, M., Incarbone, G., Bucolo, C., Drago, F., Avitabile, T. Low levels of 17-β-oestradiol, oestrone and testosterone correlate with severe evaporative dysfunctional tear syndrome in postmenopausal women: A case-control study (2014) British Journal of Ophthalmology, 98 (3), pp. 371-376, IF 2.976.
357. Salomone, S., Piazza, C., Vitale, D.C., Cardì, F., Gugliotta, B., Drago, F. Pharmacokinetics of a new subcutaneous diclofenac formulation administered to three body sites: Quadriceps, gluteus, and abdomen (2014) International Journal of Clinical Pharmacology and Therapeutics, 52 (2), pp. 129-134, IF 1.223.
356. Carta, M.G., Massidda, D., Moro, M.F., Aguglia, E., Balestrieri, M., Caraci, F., Dell’Osso, L., Di Sciascio, G., Drago, F., Faravelli, C., Hardoy, M.C., Calò, S., Pollice, R., Fortezzo, A., Akiskal, H. Comparing factor structure of the mood disorder questionnaire (MDQ): In italy sexual behavior is euphoric but in asia mysterious and forbidden (2014) Journal of Affective Disorders, 155 (1), pp. 96-103, IF 3.383.
355. Caraci, F., Drago, F. New definition of addiction proposed by the american society of addiction medicine: Which implications for the treatment of tobacco dependence? (2014) European Neuropsychopharmacology, 24 (1), pp. 1-4, IF 4.369.
354. Kucerova, J., Tabiova, K., Drago, F., Micale, V. Therapeutic potential of cannabinoids in schizophrenia (2014) Recent Patents on CNS Drug Discovery, 9 (1), pp. 13-25, IF 0.
353. Bucolo, C., Marrazzo, G., Platania, C.B.M., Romano, G.L., Drago, F., Salomone, S. Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation (2014) Journal of Pharmacy and Pharmacology, 66 (7), pp. 954-960, IF 2.264.
352. Caraci, F., Castellano, S., Salomone, S., Drago, F., Bosco, P., Di Nuovo, S. Searching for disease-modifying drugs in AD: Can we combine neuropsychological tools with biological markers? (2014) CNS and Neurological Disorders – Drug Targets, 13 (1), pp. 173-186, IF 2.628.
351. Grosso, G., Galvano, F., Marventano, S., Malaguarnera, M., Bucolo, C., Drago, F., Caraci, F. Omega-3 fatty acids and depression: Scientific evidence and biological mechanisms (2014) Oxidative Medicine and Cellular Longevity, 2014, art. no. 313570, IF 3.516.
350. D’Amico, A.G., Scuderi, S., Maugeri, G., Cavallaro, S., Drago, F., D’Agata, V. NAP Reduces Murine Microvascular Endothelial Cells Proliferation Induced by Hyperglycemia (2014) Journal of Molecular Neuroscience, 54 (3), pp. 405-413, IF 2.343.
349. Cognata, V.L., Iemmolo, R., Agata, V.D., Scuderi, S., Drago, F., Zappia, M., Cavallaro, S. Increasing the coding potential of genomes through alternative splicing: The case of PARK2 gene (2014) Current Genomics, 15 (3), pp. 203-216, IF 2.342.
348. Uva, M.G., Avitabile, T., Reibaldi, M., Bucolo, C., Drago, F., Quaranta, L., Lionetti, E., Longo, A. Long-term efficacy of latanoprost in primary congenital glaucoma (2014) Eye (Basingstoke), 28 (1), pp. 53-57, IF 2.082.
347. Grosso, G., Mistretta, A., Marventano, S., Purrello, A., Vitaglione, P., Calabrese, G., Drago, F., Galvano, F. Beneficial effects of the Mediterranean diet on metabolic syndrome (2014) Current Pharmaceutical Design, 20 (31), pp. 5039-5044, IF 3.452.
346. Grosso, G., Pajak, A., Mistretta, A., Marventano, S., Raciti, T., Buscemi, S., Drago, F., Scalfi, L., Galvano, F. Protective role of the Mediterranean diet on several cardiovascular risk factors: EVIDENCE from Sicily, southern Italy (2014) Nutrition, Metabolism and Cardiovascular Diseases, 24 (4), pp. 370-377, IF 3.39.
345. Treccani, G., Musazzi, L., Perego, C., Milanese, M., Nava, N., Bonifacino, T., Lamanna, J., Malgaroli, A., Drago, F., Racagni, G., Nyengaard, J.R., Wegener, G., Bonanno, G., Popoli, M. Stress and corticosterone increase the readily releasable pool of glutamate vesicles in synaptic terminals of prefrontal and frontal cortex (2014) Molecular Psychiatry, 19 (4), pp. 433-443, IF 14.496.
344. Marventano, S., Grosso, G., Mistretta, A., Bogusz-Czerniewicz, M., Ferranti, R., Nolfo, F., Giorgianni, G., Rametta, S., Drago, F., Basile, F., Biondi, A. Evaluation of four comorbidity indices and Charlson comorbidity index adjustment for colorectal cancer patients (2014) International Journal of Colorectal Disease, 29 (9), pp. 1159-1169, IF 2.449.
343. Treccani, G., Musazzi, L., Perego, C., Milanese, M., Nava, N., Bonifacino, T., Lamanna, J., Malgaroli, A., Drago, F., Racagni, G., Nyengaard, J.R., Wegener, G., Bonanno, G., Popoli, M. Acute stress rapidly increases the readily releasable pool of glutamate vesicles in prefrontal and frontal cortex through non-genomic action of corticosterone (2014) Molecular Psychiatry, 19 (4), p. 401, IF 14.496.
342. Malaguarnera, G., Gagliano, C., Giordano, M., Salomone, S., Vacante, M., Bucolo, C., Caraci, F., Reibaldi, M., Drago, F., Avitabile, T., Motta, M. Homocysteine serum levels in diabetic patients with non proliferative, proliferative and without retinopathy (2014) BioMed Research International, 2014, art. no. 191497, IF 1.579.
341. Navarria, A., Tamburella, A., Iannotti, F.A., Micale, V., Camillieri, G., Gozzo, L., Verde, R., Imperatore, R., Leggio, G.M., Drago, F., Di Marzo, V. The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis (2014) Pharmacological Research, 87, pp. 151-159, IF 4.408.
340. Leggio, G.M., Camillieri, G., Platania, C.B.M., Castorina, A., Marrazzo, G., Torrisi, S.A., Nona, C.N., D’Agata, V., Nobrega, J., Stark, H., Bucolo, C., Le Foll, B., Drago, F., Salomone, S. Dopamine D3 receptor is necessary for ethanol consumption: An approach with buspirone (2014) Neuropsychopharmacology, 39 (8), pp. 2017-2028, IF 7.048.
339. Carta, M.G., Preti, A., Moro, M.F., Aguglia, E., Balestrieri, M., Caraci, F., Dell’Osso, L., Di Sciascio, G., Drago, F., Faravelli, C., Hardoy, M.C., D’Aloja, E., Cossu, G., Calò, S., Palumbo, G., Bhugra, D. Eating disorders as a public health issue: Prevalence and attributable impairment of quality of life in an Italian community sample (2014) International Review of Psychiatry, 26 (4), pp. 486-492, IF 1.966.
338. Salomone, S., Drago, F., Bucolo, C. Targeting epigenetics to achieve therapeutic selectivity in disorders of the central nervous system (2013) EuroMediterranean Biomedical Journal, 8, pp. 122-129, IF 0.176.
337. D’Amico, A.G., Scuderi, S., Leggio, G.M., Castorina, A., Drago, F., D’Agata, V. Increased hippocampal CREB phosphorylation in dopamine d3 receptor knockout mice following passive avoidance conditioning (2013) Neurochemical Research, 38 (12), pp. 2516-2523, IF 2.551.
336. D’Amico, A.G., Castorina, A., Leggio, G.M., Imbesi, R., Drago, F., D’Agata, V. Dopamine D3 receptor knockout mice exhibit increased hippocampal cAMP response element binding protein (CREB) following acquisition of passive avoidance memory (2013) Italian Journal of Anatomy and Embryology, 118 (2 SUPPL), art. no. 68, IF 0.585.
335. Vitale, D.C., Piazza, C., Sinagra, T., Urso, V., Cardì, F., Drago, F., Salomone, S. Pharmacokinetic characterization of tizanidine nasal spray, a novel intranasal delivery method for the treatment of skeletal muscle spasm (2013) Clinical Drug Investigation, 33 (12), pp. 885-891, IF 1.704.
334. Salemi, M., Barone, C., Romano, C., Salluzzo, R., Caraci, F., Cantarella, R.A., Salluzzo, M.G., Drago, F., Romano, C., Bosco, P. Pericentrin expression in Down’s syndrome (2013) Neurological Sciences, 34 (11), pp. 2023-2025, IF 1.495.
333. Lupo, G., Motta, C., Giurdanella, G., Anfuso, C.D., Alberghina, M., Drago, F., Salomone, S., Bucolo, C. Role of phospholipases A2 in diabetic retinopathy: In vitro and in vivo studies (2013) Biochemical Pharmacology, 86 (11), pp. 1603-1613, IF 4.650.
332. Biondi, A., Grosso, G., Mistretta, A., Marventano, S., Toscano, C., Drago, F., Gangi, S., Basile, F. Laparoscopic vs. open approach for colorectal cancer: Evolution over time of minimal invasive surgery (2013) BMC Surgery, 13 (SUPPL.2), art. no. S12, IF 1.240.
331. Nolfo, F., Rametta, S., Marventano, S., Grosso, G., Mistretta, A., Drago, F., Gangi, S., Basile, F., Biondi, A. Pharmacological and dietary prevention for colorectal cancer (2013) BMC Surgery, 13 (SUPPL.2), art. no. S16, IF 1.240.
330. Grosso, G., Buscemi, S., Galvano, F., Mistretta, A., Marventano, S., Vela, V.L., Drago, F., Gangi, S., Basile, F., Biondi, A. Mediterranean diet and cancer: Epidemiological evidence and mechanism of selected aspects (2013) BMC Surgery, 13 (SUPPL.2), art. no. S14, IF 1.240.
329. Castorina, A., D’Amico, A.G., Scuderi, S., Leggio, G.M., Drago, F., D’Agata, V. Dopamine D3 receptor deletion increases tissue plasminogen activator (tPA) activity in prefrontal cortex and hippocampus (2013) Neuroscience, 250, pp. 546-556, IF 3.327.
328. D’Amico, A.G., Scuderi, S., Saccone, S., Castorina, A., Drago, F., D’Agata, V. Antiproliferative effects of PACAP and VIP in serum-starved glioma cells (2013) Journal of Molecular Neuroscience, 51 (2), pp. 503-513, IF 2.757.
327. Carta, M.G., Aguglia, E., Caraci, F., Dell’Osso, L., Di Sciascio, G., Drago, F., Del Giudice, E., Faravelli, C., Hardoy, M.C., Lecca, M.E., Moro, M.F., Calò, S., Casacchia, M., Angermeyer, M.C., Balestrieri, M. Erratum: Quality of Life and Urban / Rural Living: Preliminary Results of a Community Survey in Italy (Clinical Practice & Epidemiology in Mental Health (2012) 8 (169-174) (2013) Clinical Practice and Epidemiology in Mental Health, 9, p. 148, IF 2.25.
326. Platania, C.B.M., Leggio, G.M., Drago, F., Salomone, S., Bucolo, C. Regulation of intraocular pressure in mice: Structural analysis of dopaminergic and serotonergic systems in response to cabergoline (2013) Biochemical Pharmacology, 86 (9), pp. 1347-1356, IF 4.650.
325. Foresti, R., Bains, S.K., Pitchumony, T.S., De Castro Brás, L.E., Drago, F., Dubois-Randé, J.-L., Bucolo, C., Motterlini, R. Small molecule activators of the Nrf2-HO-1 antioxidant axis modulate heme metabolism and inflammation in BV2 microglia cells (2013) Pharmacological Research, 76, pp. 132-148, IF 3.976.
324. Leggio, G.M., Salomone, S., Bucolo, C., Platania, C., Micale, V., Caraci, F., Drago, F. Dopamine D3 receptor as a new pharmacological target for the treatment of depression (2013) European Journal of Pharmacology, 719 (1-3), pp. 25-33, IF 2.684.
323. Malaguarnera, G., Gagliano, C., Bucolo, C., Vacante, M., Salomone, S., Malaguarnera, M., Leonardi, D.G., Motta, M., Drago, F., Avitabile, T Lipoprotein(a) serum levels in diabetic patients with retinopathy (2013) BioMed Research International, 2013, art. no. 943505, IF 3.141.
322. Bucolo, C., Marrazzo, G., Platania, C.B.M., Drago, F., Leggio, G.M., Salomone, S. Fortified extract of red berry, ginkgo biloba, and white willow bark in experimental early diabetic retinopathy (2013) Journal of Diabetes Research, 2013, art. no. 432695, IF 0.
321. Grosso, G., Galvano, F., Mistretta, A., Marventano, S., Nolfo, F., Calabrese, G., Buscemi, S., Drago, F., Veronesi, U., Scuderi, A. Red orange: Experimental models and epidemiological evidence of its benefits on human health (2013) Oxidative Medicine and Cellular Longevity, art. no. 157240 IF 3.363.
320. Caraci, F., Drago, F. Nicotine addictions: Neurobiological circuits and pharmacological targets (2013) Advances in Smoking Cessation, pp. 25-37.
319. Tamburella, A., Leggio, G.M., Micale, V., Navarria, A., Bucolo, C., Cicirata, V., Drago, F., Salomone, S. Behavioural and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant (2013) International Journal of Neuropsychopharmacology, 16 (4), pp. 813-823, IF 5.264.
318. Caraci, F., Leggio, G.M., Drago, F., Salomone, S. Epigenetic drugs for Alzheimer’s disease: Hopes and challenges (2013) British Journal of Clinical Pharmacology, 75 (4), pp. 1154-1155, IF 3.688.
317. Di Rosa, M., Malaguarnera, G., De Gregorio, C., Drago, F., Malaguarnera, L. Evaluation of CHI3L-1 and CHIT-1 expression in differentiated and polarized macrophages (2013) Inflammation, 36 (2), pp. 482-492, IF 1.921.
316. Micale, V., Di Marzo, V., Sulcova, A., Wotjak, C.T., Drago, F. Endocannabinoid system and mood disorders: Priming a target for new therapies (2013) Pharmacology and Therapeutics, 138 (1), pp. 18-37, IF 7.745.
315. Bosco, P., Ferri, R., Salluzzo, M.G., Castellano, S., Signorelli, M., Nicoletti, F., Di Nuovo, S., Drago, F., Caraci, F. Role of the transforming-growth-factor-β1 gene in late-onset alzheimer’s disease: Implications for the treatment (2013) Current Genomics, 14 (2), pp. 147-156, IF 2.868.
314. D’Amico, A.G., Castorina, A., Leggio, G.M., Drago, F., D’Agata, V. Hippocampal neurofibromin and amyloid precursor protein expression in dopamine D3 receptor knock-out mice following passive avoidance conditioning (2013) Neurochemical Research, 38 (3), pp. 564-572, IF 2.551.
313. Sinagra, T., Tamburella, A., Urso, V., Siarkos, I., Drago, F., Bucolo, C., Salomone, S. Reversible inhibition of vasoconstriction by thiazolidinediones related to PI3K/Akt inhibition in vascular smooth muscle cells (2013) Biochemical Pharmacology, 85 (4), pp. 551-559, IF 4.650.
312. Bucolo, C., Salomone, S., Drago, F., Reibaldi, M., Longo, A., Uva, M.G. Pharmacological management of ocular hypertension: Current approaches and future prospective (2013) Current Opinion in Pharmacology, 13 (1), pp. 50-55, IF 4.227.
311. Musumeci, T., Bucolo, C., Carbone, C., Pignatello, R., Drago, F., Puglisi, G. Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits (2013) International Journal of Pharmaceutics, 440 (2), pp. 135-140, IF 3.785.
310. Platania, C.B.M., Salomone, S., Leggio, G.M., Drago, F., Bucolo, C. Erratum: Homology modeling of dopamine D2 and D3 receptors: Molecular dynamics refinement and docking evaluation (PLoS ONE (2013) 8:1 DOI: 10.1371/annotation/bd61cc74-2a2c-4433-a78d-84fa2310e919) (2013) PLoS ONE, 8 (1), art. no. A2389, IF 3.534.
309. Vitale, D.C., Piazza, C., Melilli, B., Drago, F., Salomone, S. Isoflavones: estrogenic activity, biological effect and bioavailability. (2013) European journal of drug metabolism and pharmacokinetics, 38 (1), pp. 15-25, IF 1.313.
308. Caraci, F., Bosco, P., Leggio, G.M., Malaguarnera, M., Drago, F., Bucolo, C., Salomone, S. Clinical pharmacology of novel anti-Alzheimer disease modifying medications (2013) Current Topics in Medicinal Chemistry, 13 (15), pp. 1853-1863, IF 3.453.
307. Malaguarnera, M., Drago, F., Malaguarnera, G., Li Volti, G., Salomone, S., Caraci, F., Galvano, F., Vacante, M., Bucolo, C., Malaguarnera, M. Metal fume fever (2013) The Lancet, 381 (9885), p. 2298, IF 39.207.
306. Bucolo, C., Drago, F., Salomone, S. Ocular drug delivery: A clue from nanotechnology (2012) Frontiers in Pharmacology, 3 OCT, art. no. Article 188, IF 2.388.
305. Bucolo, C., Drago, F., Salomone, S. Potential drug mechanism(s) targeting the contractile status of hepatic stellate cells (2012) Frontiers in Pharmacology, 3 OCT, art. no. Article 187, IF 2.388.
304. Carta, M.G., Aguglia, E., Caraci, F., Dell’Osso, L., Di Sciascio, G., Drago, F., Del Giudice, E., Faravelli, C., Hardoy, M.C., Lecca, M.E., Moro, M.F., Calò, S., Casacchia, M., Angermeyer, M., Balestrieri, M. Quality of life and urban / rural living: Preliminary results of a community survey in Italy (2012) Clinical Practice and Epidemiology in Mental Health, 8, pp. 169-174, IF 1.957.
303. Biondi, A., Malaguarnera, G., Vacante, M., Berretta, M., Dagata, V., Malaguarnera, M., Basile, F., Drago, F., Bertino, G. Elevated serum levels of Chromogranin A in hepatocellular carcinoma (2012) BMC Surgery, 12 (SUPPL. 1), art. no. S7, IF 1.973.
302. Uccello, M., Malaguarnera, G., Basile, F., Dagata, V., Malaguarnera, M., Bertino, G., Vacante, M., Drago, F., Biondi, A. Potential role of probiotics on colorectal cancer prevention (2012) BMC Surgery, 12 (SUPPL. 1), art. no. S35, IF 1.973.
301. Vacante, M., Dagata, V., Motta, M., Malaguarnera, G., Biondi, A., Basile, F., Malaguarnera, M., Gagliano, C., Drago, F., Salamone, S. Centenarians and supercentenarians: A black swan. Emerging social, medical and surgical problems (2012) BMC Surgery, 12 (SUPPL. 1), art. no. S36, IF 1.973.
300. Frazzetto, P., Vacante, M., Malaguarnera, M., Vinci, E., Catalano, F., Cataudella, E., Drago, F., Malaguarnera, G., Basile, F., Biondi, A. Depression in older breast cancer survivors (2012) BMC Surgery, 12 (SUPPL. 1), art. no. S14, IF 1.973.
299. Bucolo, C., Longo, L., Camillieri, G., Drago, F., Salomone, S. Safety profile assessment of buflomedil: An overview of adverse reactions between 1975 and 2011 (2012) Pharmacoepidemiology and Drug Safety, 21 (11), pp. 1190-1196, IF 2.897.
298. Platania, C.B.M., Salomone, S., Leggio, G.M., Drago, F., Bucolo, C. Homology Modeling of Dopamine D2 and D3 Receptors: Molecular Dynamics Refinement and Docking Evaluation (2012) PLoS ONE, 7 (9), art. no. e44316, IF 3.730.
297. Giunta, S., Castorina, A., Bucolo, C., Magro, G., Drago, F., D’Agata, V. Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats (2012) Peptides, 37 (1), pp. 32-39, IF 2.522.
296. Amadio, M., Osera, C., Lupo, G., Motta, C., Drago, F., Govoni, S., Pascale, A. Protein kinase C activation affects, via the mRNA-binding Huantigen R/ELAV protein, vascular endothelial growth factor expression in a pericytic/endothelial coculture model (2012) Molecular Vision, 18, pp. 2153-2164, IF 1.987.
295. Pascale, A., Drago, F., Govoni, S. Protecting the retinal neurons from glaucoma: Lowering ocular pressure is not enough (2012) Pharmacological Research, 66 (1), pp. 19-32, IF 4.346.
294. Bucolo, C., Leggio, G.M., Drago, F., Salomone, S. Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats (2012) Biochemical Pharmacology, 84 (1), pp. 88-92, IF 4.576.
293. Scapagnini, G., Davinelli, S., Drago, F., De Lorenzo, A., Oriani, G. Antioxidants as antidepressants: Fact or fiction? (2012) CNS Drugs, 26 (6), pp. 477-490 IF 4.826.
292. Tamburella, A., Micale, V., Mazzola, C., Salomone, S., Drago, F. The selective norepinephrine reuptake inhibitor atomoxetine counteracts behavioral impairments in trimethyltin intoxicated rats (2012) European Journal of Pharmacology, 683 (1-3), pp. 148-154, IF 2.592.
291. Salomone, S., Caraci, F., Leggio, G.M., Fedotova, J., Drago, F. New pharmacological strategies for treatment of Alzheimer’s disease: Focus on disease modifying drugs (2012) British Journal of Clinical Pharmacology, 73 (4), pp. 504-517, IF 3.578.
290. Caraci, F., Bosco, P., Signorelli, M., Spada, R.S., Cosentino, F.I., Toscano, G., Bonforte, C., Muratore, S., Prestianni, G., Panerai, S., Giambirtone, M.C., Gulotta, E., Romano, C., Salluzzo, M.G., Nicoletti, F., Copani, A., Drago, F., Aguglia, E., Ferri, R. The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer’s disease and is associated with AD-related depression (2012) European Neuropsychopharmacology, 22 (4), pp. 281-289, IF 4.595.
289. Bucolo, C., Leggio, G.M., Maltese, A., Castorina, A., D’Agata, V., Drago, F. Dopamine- 3 receptor modulates intraocular pressure: Implications for glaucoma (2012) Biochemical Pharmacology, 83 (5), pp. 680-686 IF 4.576.
288. Carta, M.G., Aguglia, E., Balestrieri, M., Calabrese, J.R., Caraci, F., Dell’Osso, L., Di Sciascio, G., Drago, F., Faravelli, C., Lecca, M.E., Moro, M.F., Nardini, M., Palumbo, G., Hardoy, M.C. The lifetime prevalence of bipolar disorders and the use of antidepressant drugs in bipolar depression in Italy (2012) Journal of Affective Disorders, 136 (3), pp. 775-780, IF 3.295.
287. Salomone, S., Drago, F. Effects of PPARγ ligands on vascular tone (2012) Current Molecular Pharmacology, 5 (2), pp. 282-291, IF 4.375.
286. Russo, C., Vacante, M., Malaguarnera, G., Drago, F., D’agata, V., Rampello, L., Bella, R., Pennisi, M., Malaguarnera, M., Rampello, L. Lipoprotein(A) in cerebral stroke: A review (2012) Acta Medica Mediterranea, 28 (3), pp. 201-205, IF 1.053.
285. Vecchio, M., Malaguarnera, G., Giordano, M., Malaguarnera, M., Volti, G.L., Galvano, F., Drago, F., Basile, F., Malaguarnera, M. A musician’s dystonia (2012) The Lancet, 379 (9831), p. 2116, IF 39.060.
284. Caraci, F., Spampinato, S., Sortino, M.A., Bosco, P., Battaglia, G., Bruno, V., Drago, F., Nicoletti, F., Copani, A. Dysfunction of TGF-β1 signaling in Alzheimer’s disease: Perspectives for neuroprotection (2012) Cell and Tissue Research, 347 (1), pp. 291-301 IF 3.677.
283. Bucolo, C., Musumeci, M., Musumeci, S., Drago, F. Acidic mammalian chitinase and the eye: Implications for ocular inflammatory diseases (2011) Frontiers in Pharmacology, JUL, pp. 1-4, IF 0.756.
282. Bucolo, C., Melilli, B., Piazza, C., Zurria, M., Drago, F. Ocular pharmacokinetics profile of different indomethacin topical formulations (2011) Journal of Ocular Pharmacology and Therapeutics, 27 (6), pp. 571-576, IF 1.509.
281. Carta, M.G., Tondo, L., Balestrieri, M., Caraci, F., Dell’Osso, L., Di Sciascio, G., Faravelli, C., Hardoy, M.C., Lecca, M.E., Moro, M.F., Bhat, K.M., Casacchia, M., Drago, F. Sub-threshold depression and antidepressants use in a community sample: Searching anxiety and finding bipolar disorder (2011) BMC Psychiatry, 11, art. no. 164, IF 2.552.
280. Terzian, A.L., Drago, F., Wotjak, C.T., Micale, V. The dopamine and cannabinoid interaction in the modulation of emotions and cognition: Assessing the role of cannabinoid CB1 receptor in neurons expressing dopamine D1 receptors (2011) Frontiers in Behavioral Neuroscience, (AUGUST), IF 3.926.
279. Caraci, F., Battaglia, G., Bruno, V., Bosco, P., Carbonaro, V., Giuffrida, M.L., Drago, F., Sortino, M.A., Nicoletti, F., Copani, A. TGF-β1 pathway as a new target for neuroprotection in alzheimer’s disease (2011) CNS Neuroscience and Therapeutics, 17 (4), pp. 237-249 IF 4.443.
278. Marrazzo, G., Bellner, L., Halilovic, A., Li Volti, G., Drago, F., Dunn, M.W., Laniado Schwartzman, M. The role of neutrophils in corneal wound healing in HO-2 null mice (2011) PLoS ONE, 6 (6), art. no. e21180, IF 4.092.
277. Melilli, B., Piazza, C., Vitale, D.C., Marano, M.R., Pecori, A., Mattana, P., Volsi, V.L., Iuculano, C., Cardì, F., Drago, F. Human pharmacokinetics of the muscle relaxant, eperisone hydrochloride by liquid chromatography-electrospray tandem mass spectrometry (2011) European Journal of Drug Metabolism and Pharmacokinetics, 36 (2), pp. 71-78, IF 0.356.
276. Bucolo, C., Drago, F. Carbon monoxide and the eye: Implications for glaucoma therapy (2011) Pharmacology and Therapeutics, 130 (2), pp. 191-201, IF 8.562.
275. Leggio, G.M., Micale, V., Le Foll, B., Mazzola, C., Nobrega, J.N., Drago, F. Dopamine D3 receptor knock-out mice exhibit increased behavioral sensitivity to the anxiolytic drug diazepam (2011) European Neuropsychopharmacology, 21 (4), pp. 325-332, IF 4.046.
274. Li Volti, G., Zappalà, A., Leggio, G.M., Mazzola, C., Drago, F., La Delia, F., Serapide, M.F., Pellitteri, R., Giannone, I., Spatuzza, M., Cicirata, V., Cicirata, F. Tin chloride enhances parvalbumin-positive interneuron survival by modulating heme metabolism in a model of cerebral ischemia (2011) Neuroscience Letters, 492 (1), pp. 33-38, IF 2.105.
273. Siarkos, I., Urso, V., Sinagra, T., Drago, F., Salomone, S. Endothelium-dependent vasomotor effects of telmisartan in isolated rat femoral arteries (2011) Pharmacological Research, 63 (3), pp. 199-206, IF 4.436.
272. Castorina, A., Leggio, G.M., Giunta, S., Magro, G., Scapagnini, G., Drago, F., D’Agata, V. Neurofibromin and amyloid precursor protein expression in dopamine D3 receptor knock-out mice brains (2011) Neurochemical Research, 36 (3), pp. 426-434, IF 2.240.
271. Contrafatto, D., Mostile, G., Nicoletti, A., Raciti, L., Luca, A., Dibilio, V., Lanzafame, S., Distefano, A., Drago, F., Zappia, M. Single photon emission computed tomography striatal asymmetry index may predict dopaminergic responsiveness in Parkinson disease. (2011) Clinical neuropharmacology, 34 (2), pp. 71-73, IF 2.166.
270. Caraci, F., Molinaro, G., Battaglia, G., Giuffrida, M.L., Riozzi, B., Traficante, A., Bruno, V., Cannella, M., Merlo, S., Wang, X., Heinz, B.A., Nisenbaum, E.S., Britton, T.C., Drago, F., Sortino, M.A., Copani, A., Nicoletti, F. Targeting group II Metabotropic Glutamate (mGlu) receptors for the treatment of psychosis associated with alzheimer’s disease: Selective activation of mGlu2 receptors amplifies β-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective (2011) Molecular Pharmacology, 79 (3), pp. 618-626, IF 4.883.
269. Musumeci, M., Bucolo, C., Drago, F., Musumeci, S. Acidic mammalian chitinase (AMCase): A new target for ocular diseases (2011) Drugs of the Future, 36 (2), pp. 141-148, IF 0.517.
268. Caraci, F., Crupi, R., Drago, F., Spina, E. Metabolic drug interactions between antidepressants and anticancer drugs: Focus on selective serotonin reuptake inhibitors and hypericum extract (2011) Current Drug Metabolism, 12 (6), pp. 570-577, IF 5.113.
267. Mancardi, G.L., Tedeschi, G., Amato, M.P., D’Alessandro, R., Drago, F., Milanese, C., Popoli, P., Rossi, P., Savettieri, G., Tola, M.R., Comi, G., Pozzilli, C., Bertolotto, A., Marrosu, M.G., Grimaldi, L.M.E., Laroni, A., Vanacore, N., Covezzoli, A., De Rosa, M., Piccinni, C., Montanaro, N., Periotto, L., Iommelli, R., Tomino, C., Provinciali, L. Three years of experience: The italian registry and safety data update (2011) Neurological Sciences, 31 (SUPPL. 3), pp. S295-S297, IF 1.315.
266. Kasper, S., Caraci, F., Forti, B., Drago, F., Aguglia, E. Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depression (2010) European Neuropsychopharmacology, 20 (11), pp. 747-765, IF 4.201.
265. Tamburella, A., Micale, V., Leggio, G.M., Drago, F. The β3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes (2010) European Neuropsychopharmacology, 20 (10), pp. 704-713, IF 4.201.
264. Amadio, M., Bucolo, C., Leggio, G.M., Drago, F., Govoni, S., Pascale, A. The PKCβ/HuR/VEGF pathway in diabetic retinopathy (2010) Biochemical Pharmacology, 80 (8), pp. 1230-1237, IF 4.889.
263. Drago, F., Bucolo, C. Therapeutic potential of nitric oxide modulation in ocular diseases (2010) Drug News and Perspectives, 23 (7), pp. 430-437, IF 1.867.
262. Viola, S., Merlo, S., Consoli, G.M.L., Drago, F., Geraci, C., Sortino, M.A. Modulation of C6 glioma cell proliferation by ureido-calix[8]arenes (2010) Pharmacology, 86 (3), pp. 182-188, IF 1.802.
261. Micale, V., Cristino, L., Tamburella, A., Petrosino, S., Leggio, G.M., Di Marzo, V., Drago, F. Enhanced cognitive performance of dopamine D3 receptor ” knock-out” mice in the step-through passive-avoidance test: Assessing the role of the endocannabinoid/endovanilloid systems (2010) Pharmacological Research, 61 (6), pp. 531-536, 3.612.
260. Carta, M.G., Aguglia, E., Bocchetta, A., Balestrieri, M., Caraci, F., Casacchia, M., Dell’Osso, L., Di Sciascio, G., Drago, F., Faravelli, C., Lecca, M.E., Francesca Moro, M., Morosini, P.L., Nardini, M., Palumbo, G., Hardoy, M.C. The use of antidepressant drugs and the lifetime prevalence of major depressive disorders in Italy (2010) Clinical Practice and Epidemiology in Mental Health, 6, pp. 94-100, IF 1.923.
259. Stagni, E., Bucolo, C., Motterlini, R., Drago, F. Morphine-induced ocular hypotension is modulated by nitric oxide and carbon monoxide: Role of 3 receptors (2010) Journal of Ocular Pharmacology and Therapeutics, 26 (1), pp. 31-35, IF 1.609.
258. Drago, F. David de Wied (1925-2004) (2010) European Journal of Pharmacology, 626 (1), pp. 1-2, IF 2.737.
257. Caraci, F., Copani, A., Nicoletti, F., Drago, F. Depression and Alzheimer’s disease: Neurobiological links and common pharmacological targets (2010) European Journal of Pharmacology, 626 (1), pp. 64-71, IF 2.737.
256. Bondì, M.L., Craparo, E.F., Giammona, G., Drago, F. Brain-targeted solid lipid nanoparticles containing riluzole: Preparation, characterization and biodistribution (2010) Nanomedicine, 5 (1), pp. 25-32, IF 6.202.
255. Carta, M.G., Aguglia, E., Bocchetta, A., Balestrieri, M., Caraci, F., Casacchia, M., Dell’Osso, L., Di Sciascio, G., Drago, F., Faravelli, C., Lecca, M.E., Moro, M.F., Morosini, P.L., Nardini, M., Palumbo, G., Hardoy, M.C. The use of antidepressant drugs and the lifetime prevalence of major depressive disorders in italy (2010) Clinical Practice and Epidemiology in Mental Health, 6, pp. 94-100, IF 1.923.
254. Bucolo, C., Drago, F. Focus on molecules: Heme oxygenase-1 (2009) Experimental Eye Research, 89 (6), pp. 822-823, IF 2.538.
253. Bucolo, C., Spadaro, A., Drago, F. Effects of cloricromene, a coumarin derivative, on rabbit dry eye model (2009) Journal of Pharmaceutical Sciences and Research, 1 (3), pp. 142-147, IF 0.869.
252. Bucolo, C., Ward, K.W., Mazzon, E., Cuzzocrea, S., Drago, F. Protective effects of a coumarin derivative in diabetic rats (2009) Investigative Ophthalmology and Visual Science, 50 (8), pp. 3846-3852, IF 3.431.
251. Tedeschi, G., Amato, M.P., D’Alessandro, R., Drago, F., Milanese, C., Popoli, P., Rossi, P., Savettieri, G., Tola, M.R., Vanacore, N., Covezzoli, A., De Rosa, M., Comi, G., Pozzilli, C., Bertolotto, A., Marrosu, M.G., Grimaldi, L.M.E., Piccinni, C., Montanaro, N., Periotto, L., Iommelli, R., Addis, A., Martini, N., Provinciali, L., Mancardi, G.L. The pharmacovigilance program on natalizumab in Italy: 2 Years of experience (2009) Neurological Sciences, 30 (SUPPL. 2), pp. S163-S165, IF 1.120.
250. Tamburella, A., Micale, V., Navarria, A., Drago, F. Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: Behavioral and neurochemical studies in rats (2009) Progress in Neuro-Psychopharmacology and Biological Psychiatry, 33 (7), pp. 1205-1210, IF 2.823.
249. Micale, V., Cristino, L., Tamburella, A., Petrosino, S., Leggio, G.M., Drago, F., Di Marzo, V. Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems (2009) Neurobiology of Disease, 36 (1), pp. 70-80, IF 4.518.
248. Leggio, G.M., Cathala, A., Neny, M., Rouge-Pont, F., Drago, F., Piazza, P.V., Spampinato, U. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: Differential effects of inverse agonist versus antagonist (2009) Journal of Neurochemistry, 111 (2), pp. 614-623, IF 3.999.
247. Consoli, D., Contarino, A., Tabarin, A., Drago, F. Binge-like eating in mice (2009) International Journal of Eating Disorders, 42 (5), pp. 402-408, IF 2.797.
246. Fumagalli, F., Pasini, M., Frasca, A., Drago, F., Racagni, G., Riva, M.A. Prenatal stress alters glutamatergic system responsiveness in adult rat prefrontal cortex (2009) Journal of Neurochemistry, 109 (6), pp. 1733-1744, IF 3.999.
245. Mazzola, C., Medalie, J., Scherma, M., Panlilio, L.V., Solinas, M., Tanda, G., Drago, F., Cadet, J.L., Goldberg, S.R., Yasar, S. Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-α nuclear receptors (2009) Learning and Memory, 16 (5), pp. 332-337, IF 4.079.
244. Chiechio, S., Zammataro, M., Morales, M.E., Busceti, C.L., Drago, F., Gereau IV, R.W., Copani, A., Nicoletti, F. Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain (2009) Molecular Pharmacology, 75 (5), pp. 1014-1020, IF 4.531.
243. Panlilio, L.V., Mazzola, C., Medalie, J., Hahn, B., Justinova, Z., Drago, F., Cadet, J.L., Yasar, S., Goldberg, S.R. Anandamide-induced behavioral disruption through a vanilloid-dependent mechanism in rats (2009) Psychopharmacology, 203 (3), pp. 529-538, IF 4.103.
242. Carbonaro, V., Caraci, F., Giuffrida, M.L., Merlo, S., Canonico, P.L., Drago, F., Copani, A., Sortino, M.A. Enhanced expression of ERα in astrocytes modifies the response of cortical neurons to β-amyloid toxicity (2009) Neurobiology of Disease, 33 (3), pp. 415-421, IF 4.518.
241. D’Agata, V., Tiralongo, A., Castorina, A., Leggio, G.M., Micale, V., Carnazza, M.L., Drago, F. Parkin expression profile in dopamine D3 receptor knock-out mice brains (2009) Neurochemical Research, 34 (2), pp. 327-332, IF 2.722.
240. Micale, V., Cristino, L., Tamburella, A., Petrosino, S., Leggio, G.M., Drago, F., Di Marzo, V. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels (2009) Neuropsychopharmacology, 34 (3), pp. 593-606, IF 6.993.
239. Stagni, E., Privitera, M.G., Bucolo, C., Leggio, G.M., Motterlini, R., Drago, F. A water-soluble carbon monoxide-releasing molecule (CORM-3) lowers intraocular pressure in rabbits (2009) British Journal of Ophthalmology, 93 (2), pp. 254-257, IF 2.917.
238. Tempera, G., Furneri, P.M., Cianci, A., Incognito, T., Marano, M.R., Drago, F. The impact of prulifloxacin on vaginal lactobacillus microflora: An in vivo study (2009) Journal of Chemotherapy, 21 (6), pp. 646-650, IF 1.166.
237. Viola, S., Consoli, G.M.L., Merlo, S., Drago, F., Sortino, M.A., Geraci, C. Inhibition of rat glioma cell migration and proliferation by a calix[8]arene scaffold exposing multiple GlcNAc and ureido functionalities (2008) Journal of Neurochemistry, 107 (4), pp. 1047-1055, IF 4.500.
236. Marcellino, D., Ferré, S., Casadó, V., Cortés, A., Le Foll, B., Mazzola, C., Drago, F., Saur, O., Stark, H., Soriano, A., Barnes, C., Goldberg, S.R., Lluis, C., Fuxe, K., Franco, R. Identification of dopamine D1-D3 receptor heteromers: Indications for a role of synergistic D1-D3 receptor interactions in the striatum (2008) Journal of Biological Chemistry, 283 (38), pp. 26016-26025, IF 5.520.
235. Micale, V., Tamburella, A., Leggio, G.M., Mazzola, C., Li Volsi, V., Drago, F. Behavioral effects of saredutant, a tachykinin NK2 receptor antagonist, in experimental models of mood disorders under basal and stress-related conditions (2008) Pharmacology Biochemistry and Behavior, 90 (3), pp. 463-469, IF 2.751.
234. Mancardi, G.L., Amato, M.P., D’Alessandro, R., Drago, F., Milanese, C., Popoli, P., Provinciali, L., Rossi, P., Savettieri, G., Tedeschi, G., Tola, M.R., Vanacore, N., Covezzoli, A., De Rosa, M., Piccinni, C., Montanaro, N., Periotto, L., Addis, A., Martini, N. Natalizumab: A country-based surveillance program (2008) Neurological Sciences, 29 (SUPPL. 2), pp. S235-S237, IF 1.435.
233. Drago, F. Docendo discimus: Teaching pharmacology in the modern Europe (2008) Review of Clinical Pharmacology and Pharmacokinetics, International Edition, 22 (2), p. 101.
232. Bucolo, C., Maltese, A., Drago, F. When nanotechnology meets the ocular surface (2008) Expert Review of Ophthalmology, 3 (3), pp. 325-332.
231. Micale, V., Scapagnini, G., Colombrita, C., Mazzola, C., Alkon, D.L., Drago, F. Behavioral effects of dietary cholesterol in rats tested in experimental models of mild stress and cognition tasks (2008) European Neuropsychopharmacology, 18 (6), pp. 462-471, IF 3.661.
230. Caraci, F., Battaglia, G., Busceti, C., Biagioni, F., Mastroiacovo, F., Bosco, P., Drago, F., Nicoletti, F., Sortino, M.A., Copani, A. TGF-β1 protects against Aβ-neurotoxicity via the phosphatidylinositol-3-kinase pathway (2008) Neurobiology of Disease, 30 (2), pp. 234-242, IF 4.852.
229. Leggio, G.M., Micale, V., Drago, F. Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST) (2008) European Neuropsychopharmacology, 18 (4), pp. 271-277, IF 3.661.
228. Molteni, R., Pasini, M., Moraschi, S., Gennarelli, M., Drago, F., Racagni, G., Riva, M.A. Reduced activation of intracellular signaling pathways in rat prefrontal cortex after chronic phencyclidine administration (2008) Pharmacological Research, 57 (4), pp. 296-302, IF 3.287.
227. Bucolo, C., Musumeci, M., Maltese, A., Drago, F., Musumeci, S. Effect of chitinase inhibitors on endotoxin-induced uveitis (EIU) in rabbits (2008) Pharmacological Research, 57 (3), pp. 247-252, IF 3.287.
226. Amadio, M., Scapagnini, G., Lupo, G., Drago, F., Govoni, S., Pascale, A. PKCβII/HuR/VEGF: A new molecular cascade in retinal pericytes for the regulation of VEGF gene expression (2008) Pharmacological Research, 57 (1), pp. 60-66, IF 3.287.
225. Barbiero, V.S., Giambelli, R., Musazzi, L., Tiraboschi, E., Tardito, D., Perez, J., Drago, F., Racagni, G., Popoli, M. Chronic antidepressants induce redistribution and differential activation of αcaM kinase II between presynaptic compartments (2007) Neuropsychopharmacology, 32 (12), pp. 2511-2519, IF 6.157.
224. Consoli, D., Leggio, G.M., Mazzola, C., Micale, V., Drago, F. Behavioral effects of the β3 adrenoceptor agonist SR58611A: Is it the putative prototype of a new class of antidepressant/anxiolytic drugs? (2007) European Journal of Pharmacology, 573 (1-3), pp. 139-147, IF 2.376.
223. Drago, F. Endocannabinoids and psychopathology: The therapy inside (2007) Pharmacological Research, 56 (5), pp. 357-359, IF 2.366.
222. Micale, V., Mazzola, C., Drago, F. Endocannabinoids and neurodegenerative diseases (2007) Pharmacological Research, 56 (5), pp. 382-392, , IF 2.366.
221. Tabarin, A., Diz-Chaves, Y., Consoli, D., Monsaingeon, M., Bale, T.L., Culler, M.D., Datta, R., Drago, F., Vale, W.W., Koob, G.F., Zorrilla, E.P., Contarino, A. Role of the corticotropin-releasing factor receptor type 2 in the control of food intake in mice: A meal pattern analysis (2007) European Journal of Neuroscience, 26 (8), pp. 2303-2314, 3.673.
220. Piazza, C., Privitera, M.G., Melilli, B., Incognito, T., Marano, M.R., Leggio, G.M., Roxas, M.A., Drago, F. Influence of inulin on plasma isoflavone concentrations in healthy postmenopausal women (2007) American Journal of Clinical Nutrition, 86 (3), pp. 775-780, IF 6.603.
219. Privitera, M.G., Potenza, M., Bucolo, C., Leggio, G.M., Drago, F. Hemin, an inducer of heme oxygenase-1, lowers intraocular pressure in rabbits (2007) Journal of Ocular Pharmacology and Therapeutics, 23 (3), pp. 232-239, IF 1.034.
218. Bucolo, C., Drago, F. Neuroactive steroids protect retinal tissue through σ1 receptors: Short communication (2007) Basic and Clinical Pharmacology and Toxicology, 100 (3), pp. 214-216, IF 1.821.
217. Genazzani, A.A., Biggio, G., Caputi, A.P., Del Tacca, M., Drago, F., Fantozzi, R., Canonico, P.L. Biosimilar drugs: Concerns and opportunities (2007) BioDrugs, 21 (6), pp. 351-356, IF 2.273.
216. Bonfiglio, V., Camillieri, G., Avitabile, T., Leggio, G.M., Drago, F. Effects of the COOH-terminal tripeptide α-MSH11-13 on corneal epithelial wound healing: Role of nitric oxide (2006) Experimental Eye Research, 83 (6), pp. 1366-1372, IF 2.776.
215. Neri, P.G., Stagni, E., Filippello, M., Camillieri, G., Giovannini, A., Leggio, G.M., Drago, F. Oral Echinacea purpurea extract in low-grade, steroid-dependent, autoimmune idiopathic uveitis:
1. (2006) Journal of Ocular Pharmacology and Therapeutics, 22 (6), pp. 431-436, IF 1.035.
214. Micale, V., Marco Leggio, G., Mazzola, C., Drago, F. Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia (2006) Brain Research, 1121 (1), pp. 207-215, IF 2.341.
213. Micale, V., Arezzi, A., Rampello, L., Drago, F. Melatonin affects the immobility time of rats in the forced swim test: The role of serotonin neurotransmission (2006) European Neuropsychopharmacology, 16 (7), pp. 538-545, IF 3.794.
212. Lo Pumo, R., Bellia, M., Nicosia, A., Micale, V., Drago, F. Long-lasting neurotoxicity of prenatal benzene acute exposure in rats (2006) Toxicology, 223 (3), pp. 227-234, IF 2.685.
211. Van Der Stelt, M., Mazzola, C., Esposito, G., Matias, I., Petrosino, S., De Filippis, D., Micale, V., Steardo, L., Drago, F., Iuvone, T., Di Marzo, V. Endocannabinoids and β-amyloid-induced neurotoxicity in vivo: Effect of pharmacological elevation of endocannabinoid levels (2006) Cellular and Molecular Life Sciences, 63 (12), pp. 1410-1424, IF 4.655.
210. Bucolo, C., Marrazzo, A., Ronsisvalle, S., Ronsisvalle, G., Cuzzocrea, S., Mazzon, E., Caputi, A., Drago, F. A novel adamantane derivative attenuates retinal ischemia-reperfusion damage in the rat retina through σ1 receptors (2006) European Journal of Pharmacology, 536 (1-2), pp. 200-203, IF 2.522.
209. Fumagalli, F., Frasca, A., Spartà, M., Drago, F., Racagni, G., Riva, M.A. Long-term exposure to the atypical antipsychotic olanzapine differently up-regulates extracellular signal-regulated kinases 1 and 2 phosphorylation in subcellular compartments of rat prefrontal cortex (2006) Molecular Pharmacology, 69 (4), pp. 1366-1372, IF 4.469.
208. Micale, V., Incognito, T., Ignoto, A., Rampello, L., Spartà, M., Drago, F. Dopaminergic drugs may counteract behavioral and biochemical changes induced by models of brain injury (2006) European Neuropsychopharmacology, 16 (3), pp. 195-203, IF 3.794.
207. Bonfiglio, V., Bucolo, C., Camillieri, G., Drago, F. Possible involvement of nitric oxide in morphine-induced miosis and reduction of intraocular pressure in rabbits (2006) European Journal of Pharmacology, 534 (1-3), pp. 227-232, IF 2.522.
206. Bucolo, C., Drago, F., Lin, L.-R., Reddy, V.N. Sigma receptor ligands protect human retinal cells against oxidative stress (2006) NeuroReport, 17 (3), pp. 287-291, IF 2.137.
205. Leggio, G.M., Incognito, T., Privitera, G., Marano, M.R., Drago, F. Comparative bioavailability of different formulations of levothyroxine and liothyronine in healthy volunteers (2006) Journal of Endocrinological Investigation, 29 (11), pp. RC35-RC38, IF 1.469.
204. Consoli, D., Fedotova, J., Micale, V., Sapronov, N.S., Drago, F. Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test) (2005) European Journal of Pharmacology, 520 (1-3), pp. 100-107, IF 2.477.
203. Bucolo, C., Drago, F., Lin, L.-R., Reddy, V.N. Neuroactive steroids protect retinal pigment epithelium against oxidative stress (2005) NeuroReport, 16 (11), pp. 1203-1207, IF 1.995.
202. Maltese, A., Maugeri, F., Drago, F., Bucolo, C. Simple determination of riluzole in rat brain by high-performance liquid chromatography and spectrophotometric detection (2005) Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 817 (2), pp. 331-334, IF 2.391.
201. Camillieri, G., Bucolo, C., Rossi, S., Drago, F. Hyaluronan-induced stimulation of corneal wound healing is a pure pharmacological effect (2004) Journal of Ocular Pharmacology and Therapeutics, 20 (6), pp. 548-553, IF 1.228.
200. Bucolo, C., Drago, F. Effects of neurosteroids on ischemia-reperfusion injury in the rat retina: Role of σ 1 recognition sites (2004) European Journal of Pharmacology, 498 (1-3), pp. 111-114, IF 2.432.
199. Camillieri, G., Nastasi, A., Gulino, P., Bucolo, C., Drago, F. Effects of Hyaluronan on Free-Radical Formation, Corneal Endothelium Damage, and Inflammation Parameters after Phacoemulsification in Rabbits (2004) Journal of Ocular Pharmacology and Therapeutics, 20 (2), pp. 151-157, IF 1.228.
198. Medico, M., Nicosia, A., Grech, M., Onesta, M., Sessa, G., Rampello, L., Drago, F. Riluzole restores motor activity in rats with post-traumatic peripheral neuropathy (2004) Neuroscience Letters, 358 (1), pp. 37-40, IF 2.019.
197. Alt, J., Angst, J., Backstrom, T., Baulieu, E.E., Berga, S., Birkhaeuser, M.H., Bixler, E.O., Brincat, M., Brinton, R.D., Bryant, H., Canonico, P., Cassano, G.B., Da Silva, I., Dell’Osso, L., Drago, F., Freedman, R.R., Gambacciani, M., Garcia-Segura, L.M., Genazzani, A.R., Gold, P.W., Halbreich, U., Henderson, V.W., Honjo, H., Limpaphayom, K.K., Maki, P., Martignoni, E., Mauri, M., Melcangi, R.C., Morrison, J.H., Moufarege, A., Naftolin, F., Nappi, R.E., Palacios, S., Petraglia, F., Pines, A., Riecher-Roessler, A., Sanna, E., Scarselli, G., Serra, G.B., Schmidt, P., Schneider, H.P.G., Simoncini, T., Simpson, E., Siseles, N., Solaini, G., Studd, J., Sturdee, D., Sykova, E., Swaab, D., Volpe, A., Yaffe, K., Genazzani, A.R. Hormone replacement therapy in climacteric and aging brain (2003) Gynecological Endocrinology, 17 (5), pp. 363-378, IF 0.870.
196. Mazzola, C., Micale, V., Drago, F. Amnesia induced by β-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade (2003) European Journal of Pharmacology, 477 (3), pp. 219-225, IF 2.352.
195. Castorina, M., Marino, R., Grassi, M., Drago, F. Very low doses of ethanol induce behavioral changes involving dopamine D2 receptors (2003) European Journal of Pharmacology, 477 (2), pp. 129-135, IF 2.352.
194. Nicosia, A., Giardina, L., Di Leo, F., Medico, M., Mazzola, C., Genazzani, A.A., Drago, F. Long-lasting behavioral changes induced by pre- or neonatal exposure to diazepam in rats (2003) European Journal of Pharmacology, 469 (1-3), pp. 103-109, IF 2.352.
193. Giuffrida, S., Bucolo, C., Drago, F. Topical Application of a Nitric Oxide Synthase Inhibitor Reduces Intraocular Pressure in Rabbits with Experimental Glaucoma (2003) Journal of Ocular Pharmacology and Therapeutics, 19 (6), pp. 527-534, IF 1.383.
192. Stjernschantz, J.W., Albert, D.M., Hu, D.-N., Drago, F., Wistrand, P.J. Mechanism and clinical significance of prostaglandin-induced iris pigmentation (2002) Survey of Ophthalmology, 47 (4 SUPPL. 1), pp. S162-S175, IF 3.096.
191. Drago, F., Macauda, S., Salehi, S. Small doses of melatonin increase intestinal motility in rats (2002) Digestive Diseases and Sciences, 47 (9), art. no. 450343, pp. 1969-1974, IF 1.438.
190. Drago, F., Floriddia, M.L., Cro, M., Giuffrida, S. Pharmacokinetics and bioavailability of a Ginkgo biloba extract (2002) Journal of Ocular Pharmacology and Therapeutics, 18 (2), pp. 197-202, IF 1.051.
189. Medico, M., De Vivo, S., Tomasello, C., Grech, M., Nicosia, A., Castorina, M., D’Agata, M.A., Rampello, L., Lempereur, L., Drago, F., Rampello, L. Behavioral and neurochemical effects of dopaminergic drugs in models of brain injury (2002) European Neuropsychopharmacology, 12 (3), pp. 187-194, IF 2.492.
188. Drago, F., Nicolosi, A., Micale, V., Lo Menzo, G. Placebo affects the performance of rats in models of depression: Is it a good control for behavioral experiments? (2001) European Neuropsychopharmacology, 11 (3), pp. 209-213, IF 2.437.
187. Drago, F., Frisina, M., Grech, M., Nicolosi, A., Micale, V., Nicosia, A., Medico, M., Foti, F. Dual effects of melatonin on barbiturate-induced narcosis in rats (2001) Neuroscience Letters, 300 (3), pp. 176-178, IF 2.021.
186. Drago, F., Valzelli, S., Emmi, I., Marino, A., Scalia, C.C., Marino, V. Latanoprost exerts neuroprotective activity in vitro and in vivo (2001) Experimental Eye Research, 72 (4), pp. 479-486, IF 2.180.
185. Drago, F., Arezzi, A., Virzì, A. Effects of acute or chronic administration of substituted benzamides in experimental models of depression in rats (2000) European Neuropsychopharmacology, 10 (6), pp. 437-442, IF 2.045.
184. Floriddia, M.L., Castorina, M., Drago, F. Comparative bioavailability of a new formulation of fluoxetine drops (2000) European Review for Medical and Pharmacological Sciences, 4 (1-2), pp. 9-13, IF 0.171.
183. Drago, F., Busa’, L. Acute low doses of melatonin restore full sexual activity in impotent male rats (2000) Brain Research, 878 (1-2), pp. 98-104, IF 2.526.
182. Drago, F., Lissandrello, C.O. The ‘low-dose’ concept and the paradoxical effects of prolactin on grooming and sexual behavior (2000) European Journal of Pharmacology, 405 (1-3), pp. 131-137, IF 2.236.
181. Clementi, G., Floriddia, M.L., Prato, A., Marino, A., Drago, F. Adrenomedullin and ocular inflammation in the rabbit (2000) European Journal of Pharmacology, 400 (2-3), pp. 321-326, IF 2.236.
180. Drago, F., Busà, L., Benelli, A., Bertolini, A. Acute low doses of melatonin stimulate rat sex behavior: The role of serotonin neurotransmission (1999) European Journal of Pharmacology, 385 (1), pp. 1-6, IF 2.047.
179. Rampello, L., Drago, F. Nicergoline facilitates vestibular compensation in aged male rats with unilateral labyrinthectomy (1999) Neuroscience Letters, 267 (2), pp. 93-96, IF 2.085.
178. Drago, F., Montoneri, C., Varga, C., Làszlò, F. Dual effect of female sex steroids on drug-induced gastroduodenal ulcers in the rat (1999) Life Sciences, 64 (25), pp. 2341-2350, IF 1.774.
177. Ferreira, A.F., Oliani, C., Tanasescu, C., Drago, F. Comparative bioavailability of two preparations of zopiclone [Estudo de bioequivalencia comparada de duas preparacoes de zopiclone] (1999) Revista Brasileira de Medicina, 56 (5), pp. 424-428, IF 0.247.
176. Drago, F., Di Leo, F., Giardina, L. Prenatal stress induces body weight deficit and behavioural alterations in rats: The effect of diazepam (1999) European Neuropsychopharmacology, 9 (3), pp. 239-245, IF 2.387.
175. Contarino, A., Drago, F., Zanotti, A., Natolino, F., Berti, T., Giusti, P. A new place conditioning paradigm to study tolerance to opiates in mice (1999) NeuroReport, 10 (3), pp. 517-521, IF 2.682.
174. Drago, F., Contarino, A., Busà, L. The expression of neuropeptide-induced excessive grooming behavior in dopamine D1 and D2 receptor-deficient mice (1999) European Journal of Pharmacology, 365 (2-3), pp. 125-131, IF 2.047.
173. Drago, F., Marino, A., La Manna, C. α-methyl-p-tyrosine inhibits latanoprost-induced melanogenesis in vitro (1999) Experimental Eye Research, 68 (1), pp. 85-90, IF 1.988.
172. Clementi, G., Busa, L., De Bernardis, E., Prato, A., Drago, F. Effects of centrally injected amylin on sexual behavior of male rats (1999) Peptides, 20 (3), pp. 379-382, IF 2.173.
171. Drago, F., La Manna, C., Marino, V., Marino, A., Emmi, I., Reibaldi, A. Norfloxacin exhibits negligible serum concentrations after repeated conjunctival instillation in children [2] (1998) British Journal of Clinical Pharmacology, 46 (3), pp. 272-274, IF 1.846.
170. Drago, F., La Manna, C., Emmi, I., Marino, A. Effects of sulfinpyrazone on retinae damage induced by experimental diabetes mellitus in rabbits (1998) Pharmacological Research, 38 (2), pp. 97-100, IF 0.615.
169. Drago, F., Stanciu, M., Salehi, S., Scapagnini, U. The block of central vasopressin V1 but not V2 receptors suppresses grooming behavior and hypothermia induced by intracerebroventricular vasopressin in male rats (1997) Peptides, 18 (9), pp. 1389-1392, IF 1.738.
168. Drago, F., Busǎ, L. Dose-dependent effects of acute kainic acid treatment on sexual behavior of male rats (1997) Brain Research, 778 (1), pp. 135-139, IF 2.119.
167. Montoneri, C., Drago, F. Effects of pregnancy in rats on cysteamine-induced peptic ulcers: Role of progesterone (1997) Digestive Diseases and Sciences, 42 (12), pp. 2572-2575, IF 1.875.
166. László, F., Varga, C., Montoneri, C., Drago, F. Damaging actions of testosterone on cysteamine-induced gastroduodenal ulceration and vascular leakage in the rat (1997) European Journal of Pharmacology, 337 (2-3), pp. 275-278, IF 1.960.
165. Drago, F., Montoneri, C. Influence of growth hormone on cysteamine-induced gastroduodenal lesions in rats: The involvement of somatostatin (1997) Life Sciences, 61 (1), pp. 21-28, IF 2.275.
164. Contarino, A., Zanotti, A., Drago, F., Natolino, F., Lipartiti, M., Giusti, P. Conditioned place preference: No tolerance to the rewarding properties of morphine (1997) Naunyn-Schmiedeberg’s Archives of Pharmacology, 355 (5), pp. 589-594, if 2.451.
163. Drago, F., Montoneri, C. Growth hormone and somatostatin interaction in the ulcerogenic effect of cysteamine in female rats (1997) Journal of Physiology Paris, 91 (3-5), pp. 127-130.
162. Blasco, G., Traversa, U., Drago, F. Effects of nicergoline on rabbit electroretinogram during recovery after ischaemia in light and dark (1997) Pharmacological Research, 36 (5), pp. 363-368, IF 0.470.
161. Drago, F., Emmi, I., Marino, V. Effects of beta-blockers association with pilocarpine on rabbit intraocular pressure and heart rate (1997) Pharmacological Research, 35 (4), pp. 299-302, IF 0.470.
160. Rampello, L., Raffaele, R., Nicoletti, G., Le Pira, F., Vecchio, I., Malaguarnera, M., Drago, F. Neurobehavioral syndrome induced by H2-receptor blocker withdrawal: Possible role of prolactin (1997) Clinical Neuropharmacology, 20 (1), pp. 49-54, IF 1.604.
159. Drago, F., Contarino, A., Marino, R., Anzallo, C., Valerio, C., Rampello, L., Raffaele, R., Scapagnini, U. Effects of acute or chronic administration of risperidone on motor and sexual behavior of male rats (1997) Pharmacological Research, 35 (1), pp. 17-25, IF 0.470.
158. Drago, F., Musco, S., Nardo, L., Valerio, C., Grassi, M., Rampello, L. Behavioral and neurochemical alterations induced by reversible conductive hearing loss in aged male rats (1996) Neuroscience Letters, 205 (1), pp. 1-4, IF 1.768.
157. D’Agata, V., Drago, F., Uva, M.G., Reibaldi, A.Immunoistochemical distribution and molecular expression of ocular receptors for Pituitary Adenylate Cyclase Activating Polypeptide (PACAP)(1996) Investigative Ophthalmology and Visual Science, 37 (3), pp. S634, IF 5.250.
156. Drago, F., Nardo, L., Rampello, L., Raffaele, R.Vestibular compensation in aged rats with unilateral labyrinthectomy treated with dopaminergic drugs(1996) Pharmacological Research, 33 (2), pp. 135-140, IF 0.470.
155. Clementi, G., Valerio, C., Emmi, I., Prato, A., Drago, F. Behavioral effects of amylin injected intracerebroventricularly in the rat(1996) Peptides, 17 (4), pp. 589-591, IF 1.738.
154. Drago, F., Di Leo, F., Ikonomou, S., Anzallo, C., Busà, L., Lo Presti, L. Behavioral and endocrine effects of growth hormone administration in aged female rats (1996) Psychoneuroendocrinology, 21 (4), pp. 401-410, IF 1.992.
153. Drago, F., Coppi, G., Antonuzzo, P.A., Valerio, C., Genazzani, A.A., Grassi, M., Raffaele, R., Scapagnini, U. Effects of RGH 2202 on cognitive and motor behavior of the rat (1996) Neurobiology of Aging, 17 (1), pp. 67-71, IF 2.872.
152. Cavallaro, S., D’Agata, V., Drago, F., Musco, S., Nuciforo, G., Ricciardolo, F., Travali, S., Stivala, F., Arimura, A., Canonico, P.L.Ocular expression of type-I pituitary adenylate cyclase-activating polypeptide (PACAP) receptors (1996) Annals of the New York Academy of Sciences, 805, pp. 555-557, IF 0.903.
151. Rampello, L., Nicoletti, G., Raffaele, R., Drago, F. Comparative effects of amitriptyline and amineptine in patients affected by anxious depression (1995) Neuropsychobiology, 31 (3), pp. 130-134, IF 0.821.
150. Drago, F., D’Agata, V., Marino, V., Marino, A., Blasco, G. Biochemical changes induced by pyrphenoxone in the lens of rabbits and rats (1995) Pharmacological Research, 31 (5), pp. 325-329, IF 0.470.
149. Drago, F., De Bernardis, E. Lachrymal concentration of norfloxacin after a single ocular instillation in humans (1994) European Journal of Ophthalmology, 4 (2), pp. 102-104, IF 0.541.
148. Drago, F., Dal Bello, A., Marino, V., Pisati, R., Lodola, E., Barbieri, P. Evaluation of the effect of thymoxamine solution 0.5% on mydriasis induced by ibopamine solution 1% (1993) European Journal of Clinical Pharmacology, 44 (5), pp. 477-480, IF 1.219.
147. Grassi, M., Drago, F. Effects of oxytocin on emotional stress and stress-induced gastric lesions (1993) Journal of Physiology – Paris, 87 (4), pp. 261-264, IF 0.707.
146. Drago, F., Grassi, M., Genazzani, A.A. Neuromediators in aging and gastric mucosal injury (1993) Journal of Physiology Paris, 87 (6), pp. 379-383, IF IF 0.707.
145. D’Agata, V., Drago, F., Serapide, F., Cicirata, F. Effects of cerebellectomy on motivation-related behavior: A time-course study (1993) Physiology and Behavior, 53 (1), pp. 173-176, IF 1.250.
144. Falsaperla, A., Sicurella, L., Abu Zied, N., Rampello, L., Drago, F. Therapeutic efficacy of a 30-300 KD protein fraction vs. gangliosides in the treatment of diabetes neuropathy. A pilot study (1993) Acta Therapeutica, 19 (3), pp. 275-281, IF 0.444.
143. Drago, F., Mauceri, F., Nardo, L., Valerio, C., Genazzani, A.A., Grassi, M. Effects of cytidine-diphosphocholine on acetylcholine-mediated behaviors in the rat (1993) Brain Research Bulletin, 31 (5), pp. 485-489, IF 1.708.
142. Iurato, M.P., Chiarenza, A., Barbera, N., Cantarella, G., Lempereur, L., Drago, F., Scapagnini, U., Bernar dini, R. Thymic factors influence on behavior in rodents (1993) Pharmacology, Biochemistry and Behavior, 44 (3), pp. 665-671, IF 1.480.
141. Drago, F., Agnoli, A., Avanzini, G., Azzena, G.B., Conticello, S., De Vincentiis, I., Dufour, A., Manni, E., Mira, E., Modugno, C. The definition of a reference protocol for the clinical study of vertigo drugs [Definizione di un protocollo quadro per lo studio clinico di farmaci antivertiginosi.] (1992) Acta Otorhinolaryngologica Italica, 12 (3), pp. 303-308, IF 0.427.
140. Drago, F., D’Agata, V., Guidi, G. Effects of t-α-glycerylphosphorylcholine on drug-lnduced behavioral alterationsin rats (1992) Dementia and Geriatric Cognitive Disorders, 3 (1), pp. 7-9, IF 0.710.
139. Drago, F., Mauceri, F., Valerio, C., Lauria, N. Effects of a protein fraction (M.W. 30-300 KD) on the recovery of sensorimotor function in the rat (1992) Acta Therapeutica, 18 (1), pp. 75-80, IF 0.444.
138. Grassi, M., Clementi, G., Prato, A., Valerio, C., Drago, F. Effects of calcitonin-gene related peptide on some behavioral parameters (1992) Pharmacological Research, 26 (SUPPL. 1), p. 256, IF 0.470, IF 0.470.
137. Drago, F., Mauceri, F., Nardo, L., Valerio, C., Lauria, N., Rampello, L., Guidi, G. Behavioral effects of L-α-glycerylphosphorylcholine: Influence on cognitive mechanisms in the rat (1992) Pharmacology, Biochemistry and Behavior, 41 (2), pp. 445-448, IF 1.480.
136. Drago, F., Valerio, C., Nardo, L., Genazzani, A.A., D’Agata, V., Mauceri, F., Freni, V. Cerebral effects of dihydroergocristine [ZEREBRALE WIRKUNGEN VON DIHYDROERGOCRISTIN] (1992) Arzneimittel-Forschung/Drug Research, 42 (11 A), pp. 1391-1394, IF 0.627.
135. Drago, F., Mauceri, F., Fidilio, M., Cavaliere, S., Pulvirenti, L., Foti, F. Effects of thyrotropin releasing hormone, oxytocin and prolactin on thiopenthal-induced narcosis in rats (1992) Brain Research Bulletin, 28 (5), pp. 781-783, IF 1.708.
134. Clementi, G., Grassi, M., Valerio, C., Prato, A., Fiore, C.E., Drago, F. Effects of calcitonin gene-related peptide on extrapyramidal motor system (1992) Pharmacology, Biochemistry and Behavior, 42 (3), pp. 545-548, IF 1.480.
133. Raffaele, R., Cosentino, E., Anicito, M.B., Sciacca, A., Rampello, L., Pennisi, G., Genazzani, A.A., Bosco, G., Casabona, A., Drago, F. Effects of TRH-T on spinal motoneurones in man (1992) NeuroReport, 3 (11), pp. 1017-1018, IF 2.262.
132. Drago, F., Sarnyai, Z., D’Agata, V. The inhibition of oxytocin-induced grooming by a specific receptor antagonist (1991) Physiology and Behavior, 50 (3), pp. 533-536, IF 1.250.
131. Rampello, L., Nicoletti, G., Drago, F. The dopaminergic hypothesis for hysterical neurosis of the conversion type: A study with sulpiride, haloperidol and amineptine (1991) Acta Therapeutica, 17 (2), pp. 195-202, IF 0.444.
130. Rampello, L., Nicoletti, G., Drago, F. Flunarizine-induced extrapyramidal and depressive symptoms: A clinical model of central dopaminergic impairment (1991) Acta Therapeutica, 17 (3), pp. 307-310, IF 0.444.
129. Drago, F., Grassi, M., Valerio, C., Coppi, G., Lauria, N., Nicotra, G.C., Raffaele, R. Behavioral changes induced by the thyrotropin-releasing hormone analogue, RGH 2202 (1991) Peptides, 12 (6), pp. 1309-1313, IF 1.738.
128. Raffaele, R., Cosentino, E., Anicito, B., Rampello, L., Drago, F., Nardo, L. Effects of levocarnitine acetyl on motor disturbances of diabetic rats (1991) Acta Therapeutica, 17 (4), pp. 363-367, IF 0.444.
127. Drago, F., Spadaro, F., D’Agata, V., Valerio, C., Grassi, M., Mauceri, F., Pennisi, G., Scapagnini, U. Protective action of phosphatidylserine on stress-induced behavioral and autonomic changes in aged rats (1991) Neurobiology of Aging, 12 (5), pp. 437-440, IF 2.872.
126. Reibaldi, A., Spampinato, D., Cavaliere, S., Rapisarda, E., Cavallaro, N., Caruso, P., Dal Bello, A. Drago, F. Effects of Nd-Yag laser vitreolysis on lens and vitreous prostaglandins in the rabbit eye (1991) Metabolic, Pediatric and Systemic Ophthalmology, 14 (2), pp. 44-46, IF 0.
125. Cavaliere, S., Spampinato, D., Caruso, P., Dal Bello, A., Reibaldi, A., Drago, F. Effects of hyaluronic acid fractions in the rabbit eye. (1990) Annals of Ophthalmology, 22 (11), pp. 429-431, IF 0.126.
124. Grassi, M., Fossati, A., Drago, F. Pharmacokinetic study of bromperidol after oral and intramuscular administration in rabbits (1990) Pharmacological Research, 22, p. 240, IF 0.470, IF 0.470.
123. Drago, F., Pulvirenti, L., Spadaro, F., Pennisi, G. Effects of TRH and prolactin in the behavioral despair (swim) model of depression in rats (1990) Psychoneuroendocrinology, 15 (5-6), pp. 349-356, IF 1.992.
122. Genazzani, A., Mauceri, F., Valerio, C., Nardo, L., Drago, F. Effects of risperidone on motor and sexual activity in the rat (1990) Pharmacological Research, 22 (SUPPL. 1), pp. 61-62, IF 0.470.
121. Drago, F., D’agata, V., Spadaro, F., Grassi, M., Valerio, C. Prolactin as a Protective Factor in Stress‐Induced Gastric Ulcers (1990) Annals of the New York Academy of Sciences, 597 (1), pp. 248-251, IF 0.903.
120. Genazzani, A.A., Pulvirenti, G., Mauceri, F., Grassi, M., Drago, F. The effect of chronic stress on the pharmacological effect of antidepressants (1990) Pharmacological Research, 22, p. 224, IF 0.470, IF 0.470.
119. Tassorelli, C., Spampinato, D., Caruso, P., Cavaliere, S., Micieli, G., Drago, F., Nappi, G. Neurotensin-induced miosis: The role of dopaminergic pathways (1990) Peptides, 11 (6), pp. 1309-1311, IF 1.738.
118. Spampinato, D., Cavaliere, S., Dal Belles, A., Caruso, P., Marino, V., Drago, F. Role OF D1 and D2 receptors in the regulation of intraocular pressure (1990) Pharmacological Research, 22 (SUPPL. 1), pp. 57-58, IF 0.470.
117. Pulvirenti, G., Valerio, C., Spadaro, F., D’Agata, V., Freni, V., Nardo, L., Drago, F. Acetylcarnitine reduces the immobility of rats in a despair test (constrained swim) (1990) Behavioral and Neural Biology, 54 (2), pp. 110-114, IF 0.
116. Drago, F., Grassi, M., Valerio, C., Spadaro, F., D’Agata, V., Lauria, N. Effects of vinburnine on experimental models of learning and memory impairments (1990) Pharmacology, Biochemistry and Behavior, 37 (1), pp. 53-57, IF 1.480.
115. Drago, F., D’Agata, V., Valerio, C., Spadaro, F., Raffaele, R., Nardo, L., Grassi, M., Freni, V. Memory deficits of aged male rats can be improved by pyrimidine nucleosides and n-acetyl-glutamine (1990) Clinical Neuropharmacology, 13 (4), pp. 290-296, IF 1.604.
114. Drago, F., Valerio, C., D’Agata, V., Spadaro, F., Astuto, C., Lauri a, N., Raffaele, R. Pharmacological rationale for the use of CDP-choline in chronic cerebrovascular diseases [RAZIONALE FARMACOLOGICO DELL’IMPIEGO DELLA CDP-COLINA NELLE CEREBROVASCULOPATIE CRONICHE] (1989) Annali Italiani di Medicina Interna, 4 (3 II), pp. 261-267, IF 0.
113. Valerio, C., Clementi, G., Spadaro, F., D’Agata, V., Raffaele, R., Grassi, M., Lauria, N., Drago, F. The effects of acetyl-L-carnitine on experiental models of learning and memory deficits in the old rat (1989) Functional Neurology, 4 (4), pp. 387-390, IF 0.412.
112. Clementi, G., Valerio, C., Prato, A., Caruso, A., Patti, F., Patanè, S., Drago, F. Effects of calcitonin on morphine tolerance and withdrawal syndrome in morphine physically dependent rats (1989) European Journal of Pharmacology, 163 (1), pp. 175-179, IF 1.960.
111. Drago, F., Gagliano, C., Cavaliere, S. Aging related changes of neurotransmitters in the visual system (1989) Metabolic, Pediatric and Systemic Ophthalmology, 12 (1-3), pp. 21-23, IF 0.
110. Cavaliere, S., Caruso, P., Spampinato, D., Drago, F. Neurochemical mechanisms of neurotensin-induced miosis (1989) Pharmacological Research, 21, pp. 49-50, IF 0.470.
109. Spadaro, F., Drago, F., Hernandez, D.E., Scapagnini, U. Behavioral Changes Induced by Neonatal Administration of TRH Antiserum (1989) Annals of the New York Academy of Sciences, 553 (1), pp. 517-518, IF 0.903.
108. Drago, F., Spadaro, F., D’Agata, V., Grassi, M., Valsecchi, B. (-)Deprenyl improves behavioral deficits of aged rats after oral administration (1989) New Trends in Clinical Neuropharmacology, 3 (2), p. 133, IF 2.166.
107. Drago, F., Valerio, C., D’Agata, V., Spadaro, F., Astuto, C., Manzone, G., Lauria, N. Effects of dihydroergocristine on experimental models of vertigo (1989) Acta Therapeutica, 15 (4), pp. 385-394, IF 0.444.
106. D’Agata, V., Spampinato, G., Iacona, T., Spadaro, F., Messina, L., Messina, A., Drago, F. Effects of trh on the immune system of newborn rats (1989) Pharmacological Research, 21, pp. 47-48, IF 0.470.
105. Drago, F., D’Agata, V., Iacona, T., Spadaro, F., Grassi, M., Valerio, C., Astuto, C., Lauria, N., Raffaele, R., Vitetta, M. Prolactin as a protective factor in stress‐induced biological changes (1989) Journal of Clinical Laboratory Analysis, 3 (6), pp. 340-344, IF 1.182.
104. Drago, F. The Role of Prolactin in Rat Grooming Behavior (1988) Annals of the New York Academy of Sciences, 525 (1), pp. 237-244, IF 0.903.
103. Spadaro, F., Drago, F., Scapagnini, U. Prolactin affects central dopamine receptor function: A behavioral model in aged rats (1988) Pharmacological Research Communications, 20 (SUPPL. 2), p. 366, IF 0.470.
102. Spadaro, F., Drago, F., Scapagnini, U. The bioinactivation of cerebral TRH by a specific antiserum affects neonatal and adult behavior of the rat (1988) Pharmacological Research Communications, 20 (3), pp. 217-218, IF 0.470.
101. D’Agata, V., Spadaro, F., Drago, F. Dihydroergocristine improves behavioral deficits of aged rats (1988) Pharmacological Research Communications, 20 (12), pp. 1119-1120, IF 0.470.
100. Drago, F., Spadaro, F., Scapagnini, U. Prolactin affects central dopamine receptor function: The behavioral model of aged rats (1988) Pharmacological Research Communications, 20 (12), pp. 1101-1102, IF 0.470.
99. Drago, F., Valerio, C., D’agata, V., Lauria, N., Scapagnini, U. Dihydroergocryptine improves behavioral deficits of aged male rats (1988) Neurobiology of Aging, 9 (C), pp. 285-290, IF 2.872.
98. Drago, F., Valerio, C., Scalisi, b., D’Agata, V., Scapagnini, U. Dihydroergocristine and memory alterations of aged male rats (1988) Pharmacology, Biochemistry and Behavior, 30 (4), pp. 961-965, IF 1.480.
97. Pedersen, C.A., Caldwell, J.D., Drago, F., Noonan, L.R., Peterson, G., Hood, L.E., Prange, A.J., Jr. Grooming Behavioral Effects of Oxytocin: Pharmacology, Ontogeny, and Comparisons with Other Nonapeptides (1988) Annals of the New York Academy of Sciences, 525 (1), pp. 245-256, IF 0.903.
96. Nicoletti, F., Valerio, C., Pellegrino, C., Drago, F., Scapagnini, U., Canonico, P.L. Spatial Learning Potentiates the Stimulation of Phosphoinositide Hydrolysis by Excitatory Amino Acids in Rat Hippocampal Slices (1988) Journal of Neurochemistry, 51 (3), pp. 725-729, IF 0.
95. Drago, F., Valerio, C., D’Agata, V., Astuto, C., Spadaro, F., Continella, G., Scapagnini, U. Pyroglutamic acid improves learning and memory capacities in old rats (1988) Functional Neurology, 3 (2), pp. 137-143, IF 0.412.
94. Drago, F., Cavallaro, N., Dal Bello, A., Cavaliere, S., Spampinato, D., Gorgone, G. Hyperprolactinaemia increases intraocular pressure in humans (1987) Metabolic, Pediatric and Systemic Ophthalmology, 10 (3), pp. 76-78, IF 0.
93. Romano, G., Salemi, S., Cancemi, G., Tripi, F., Rasa, R., Drago, F. Rifampicin concentration in the rat parotid gland [PENETRAZIONE DELLA RIFAMPICINA MARCATA NELLA GHIANDOLA PAROTIDE DEL RATTO] (1987) European Review for Medical and Pharmacological Sciences, 9 (3), pp. 345-347, IF 0.773.
92. Saraniti, G., Cavaliere, S., Dal Bello, A., Spampinato, D., Drago, F. Dopaminergic system in the retina of rabbits and its interaction with TRH [Système dopaminergique dans la rétine du lapin et son interaction avec de la TRH.] (1987) Ophtalmologie : organe de la Societe francaise d”ophtalmologie, 1 (4), pp. 515-517, IF 0.
91. Drago, F., Continella, G., Valerio, C., D’Agata, V., Astuto, C., Spadaro, F., Scapagnini, U. Effects of pyroglutamic acid on learning and memory processes of the rat (1987) Acta Therapeutica, 13 (6), pp. 587-594, IF 0.444.
90. Valerio, C., D’Agata, V., Spadaro, F., Astuto, C., Lauria, N., Drago, F. Effects of betahistine on behavioural alterations induced by hypoxic hypoxia and chronic cerebrovascular insufficiency (1987) Acta Therapeutica, 13 (6), pp. 599-607, IF 0.444.
89. Dal Bello, A., Gagliano, C., Cavaliere, S., Spampinato, D., Reibaldi, A., Guarcello, V., Drago, F. Distribution of rifampicin in ocular tissues after systemic administration (1987) Acta Therapeutica, 13 (6), pp. 595-598, IF 0.444.
88. Drago, F., Scapagnini, U. Hormonal modulation of central dopaminergic transmission. (1986) Journal of Neural Transmission, Supplement, 22, pp. 47-54, IF 0.803.
87. Drago, F., Valerio, C., Clementi, G., Scapagnini, U. Effects of flunarizine on experimentally-induced convulsions in animals (1986) Functional Neurology, 1 (4), pp. 529-532, IF 0.412.
86. Drago, F., Continella, G., Spadaro, F., Cavaliere, S., Scapagnini, U. Behavioral effects of deprenyl in aged rats (1986) Functional Neurology, 1 (2), pp. 165-174, IF 0.412.
85. Drago, F., Van Ree, J.M., De Wied, D. Desenkephalin-γ-endorphin restores the impaired sensitivity of hypophysectomized rats to small doses of apomorphine (1986) European Journal of Pharmacology, 128 (3), pp. 205-212, IF 1.960.
84. Drago, F., Pedersen, C.A., Caldwell, J.D., Prange Jr., A.J. Oxytocin potently enhances novelty-induced grooming behavior in the rat (1986) Brain Research, 368 (2), pp. 287-295, IF 1.708.
83. Drago, F., Bohus, B. Hyperprolactinaemia alleviates behavioral alterations of rats with hereditary hypothalamic diabetes insipidus (Brattleboro strain) (1986) Physiology and Behavior, 38 (4), pp. 517-523, IF 1.250.
82. Cavaliere, S., Spampinato, D., Lauria, N., Drago, F. Accelerated recovery of corneal ulcers in rabbits treated with an extract derived from Triticum vulgare (1986) Acta Therapeutica, 12 (2), pp. 179-184, IF 0.444.
81. Caldwell, J.D., Drago, F., Prange Jr., A.J., Pedersen, C.A. A comparison of grooming behavior potencies of neurohypophyseal nonapeptides (1986) Regulatory Peptides, 14 (3), pp. 261-271, IF 1.841.
80. Patti, F., Drago, F., Marano, P., Nicoletti, F., Scapagnini, U. Effect of sulpiride on chronic abstinence syndrome in addicted patients (1986) Clinical Neuropharmacology, 9 (5), pp. 469-476, IF 1.604.
79. Hernandez, D.E., Drago, F., Mason, G.A., Stanley, D.A., Prange Jr., A.J. Effect of dopamine agonists and antagonists on neurotensin-induced antinociception (1986) Pharmacology, Biochemistry and Behavior, 24 (3), pp. 425-428, IF 1.480.
78. Drago, F., Continella, G., Pennisi, G., Alloro, M.C., Calvani, M., Scapagnini, U. Behavioral effects of acetyl-l-carnitine in the male rat (1986) Pharmacology, Biochemistry and Behavior, 24 (5), pp. 1393-1396, IF 1.480.
77. Drago, F., Bohus, B., Bitetti, R., Scapagnini, U., van Ree, J.M., de Wied, D. Intracerebroventricular injection of anti-prolactin serum suppresses excessive grooming of pituitary homografted rats (1986) Behavioral and Neural Biology, 46 (1), pp. 99-105, IF 0.
76. Drago, F., Caldwell, J.D., Pedersen, C.A., Continella, G., Scapagnini, U., Prange Jr., A.J. Dopamine neurotransmission in the nucleus accumbens may be involved in oxytocin-enhanced grooming behavior of the rat (1986) Pharmacology, Biochemistry and Behavior, 24 (5), pp. 1185-1188, IF 1.480.
75. Brambilla, F., Aguglia, E., Massironi, R., Maggioni, M., Grillo, W., Castiglioni, R., Catalano, M., Drago, F. Neuropeptide therapies in chronic schizophrenia: TRH and vasopressin administration (1986) Neuropsychobiology, 15 (3-4), pp. 114-12, IF 0.821.
74. Drago, F., Scapagnini, U. Side effects of drugs stimulating prolactin secretion on the behavior of male rats (1985) Archives Internationales de Pharmacodynamie et de Therapie, 276 (2), pp. 271-278, IF 1.267.
73. Drago, F., Continella, G., Alloro, M.C., Scapagnini, U. Behavioral effects of perinatal administration of antidepressant drugs in the rat (1985) Neurobehavioral Toxicology and Teratology, 7 (5), pp. 493-497, IF 2.983.
72. Drago, F., Continella, G. Somatic growth in hypophysectomized pituitary-homografted rats is promoted by prolactin (1985) Experientia, 41 (11), pp. 1442-1444, IF 1.344.
71. Drago, F., Continella, G., Mason, G.A., Hernandez, D.E., Scapagnini, U. Phospholipid liposomes potentiate the inhibitory effect of antidepressant drugs on immobility of rats in a despair test (constrained swim) (1985) European Journal of Pharmacology, 115 (2-3), pp. 179-184, IF 1.960.
70. Drago, F., Continella, G., Mangano, O., Canonico, P.L., Bernardini, R., Scapagnini, U. Neuroendocrine and behavioral effects of flunarizine in young and old rats (1985) Cephalalgia, 5 (SUPPL. 2), pp. 125-129, IF 2.234.
69. Drago, F., Scapagnini, U. Effects of endogenous hyperprolactinaemia on opiate-induced behavioral changes in rats (1985) Brain Research, 336 (2), pp. 215-221, IF 1.708.
68. Drago, F., Aguglia, E., Dal Bello, A., Panissidi, G.B., Bellomio, F., Spampinato, D., Gorgone, G. Ocular instillation of naloxone increases intraocular pressure in morphine-addicted patients: A possible test for detecting misuse of morphine (1985) Experientia, 41 (2), pp. 266-267, IF 1.344.
67. Drago, F., Continella, G., Conforto, G., Scapagnini, U. Prolactin inhibits the development of stress-induced ulcers in the rat (1985) Life Sciences, 36 (2), pp. 191-197, IF 2.275.
66. Drago, F., Continella, G., Scapagnini, U. Behavioral and neurochemical changes in long-term hyperprolactinemia. (1985) Advances in biochemical psychopharmacology, 40, pp. 47-58, IF 0.
65. Villardita, C., Rodolico, F., Cupone, V., Drago, F. Effects of a pharmacological combination of l-glutamine, dl-phosphorylserine, l-asparagine and pyridoxine on cognitive disturbances in children (1985) Acta Therapeutica, 11 (3), pp. 301-308, IF 0.444.
64. Continella, G., Drago, F., Auditore, S., Scapagnini, U. Quantitative alteration of grooming behavior in aged male rats (1985) Physiology and Behavior, 35 (6), pp. 839-841, IF 1.250.
63. Drago, F., Kovács, G.L., Szabo, G., Scapagnini, U., Telegdy, G. Effects of haloperidol on morphine-induced antinociception morphine tolerance and withdrawal in hyperprolactinaemic rats (1985) Neuropharmacology, 24 (11), pp. 1027-1031, IF 3.909.
62. Hernandez, D.E., Simons, K.B., Spampinato, D., Peiffer Jr., R.L., Drago, F. Intracameral administration of α-MSH increases intraocular pressure in rabbits (1985) Neuropeptides, 6 (6), pp. 553-560, IF 0.905.
61. Drago, F., Panissidi, G., Bellomio, F., Belle, A.D., Aguglia, E., Gorgone, G. EFFECTS OF OPIATES AND OPIOIDS ON INTRAOCULAR PRESSURE OF RABBITS AND HUMANS (1985) Clinical and Experimental Pharmacology and Physiology, 12 (2), pp. 107-113, IF 0.938.
60. Ferrara, N., Bernardini, R., Nicoletti, F., Drago, F., Matera, M., Ceravolo, A., Scapagnini, U. Prolactin influences sexual behavior during aging. (1985) Journal of Endocrinological Investigation, 8 Suppl 2, pp. 23-32, IF 0.613.
59. Kovács, G.L., Drago, F., Acsai, L., Tihanyi, Á., Scapagnini, U., Telegdy, G. Catecholamine utilization in specific rat brain nuclei after short-term hyperprolactinaemia (1984) Brain Research, 324 (1), pp. 29-34, IF 1.708.
58. Drago, F., Sortino, G., Romano, G. Effects of perinatal injection of epidermal growth factor on the eruption of incisor tooth, and body and fur growth in the rat (1984) European Review for Medical and Pharmacological Sciences, 6 (2), pp. 395-398, IF 0.773.
57. Aguglia, E., Drago, F., Continella, G. Central nervous system effects of TRH [EFFETTI CENTRALI DEL THYROTROPIN-RELEASING HORMONE (TRH)] (1984) European Review for Medical and Pharmacological Sciences, 6 (3), pp. 491-494, IF 0.773.
56. Consoli, V., Drago, F., Battaglia, R. Cerebrospinal fluid brain peptides in patients with cerebral haemorrhage [MODIFICAZIONI DELLA CONCENTRAZIONE LIQUORALE DI NEUROPEPTIDI IN PAZIENTI CON EMORRAGIA CEREBRALE: IMPLICAZIONI TERAPEUTICHE] (1984) European Review for Medical and Pharmacological Sciences, 6 (1), pp. 49-54, IF 0.773.
55. Drago, F., Caccamo, G., Continella, G., Scapagnini, U. Amphetamine-induced analgesia does not involve brain opioids (1984) European Journal of Pharmacology, 101 (3-4), pp. 267-269, IF 1.960.
54. Drago, F. Prolactin and sexual behavior: A review (1984) Neuroscience and Biobehavioral Reviews, 8 (4), pp. 433-439, IF 2.786.
53. Drago, F., Scapagnini, U. Side effects of drugs stimulating prolactin secretion on the behavior of male rats (1984) Archives of Toxicology, 55 (SUPPL. 7), pp. 508-509, IF 1.068.
52. Drago, F., Amir, S. Effects of hyperprolactinaemia on core temperature of the rat (1984) Brain Research Bulletin, 12 (4), pp. 355-358, IF 1.708.
51. Drago, F., Continella, G., Scapagnini, U. Behavioral activity of a short chain ACTH analog (1984) Pharmacology, Biochemistry and Behavior, 20 (5), pp. 689-695, IF 1.480.
50. Continella, G., Drago, F., Amico-Roxas, M., Scapagnini, U. Effects of valproic acid derivatives on the acquisition of active avoidance behavior in the rat (1984) Pharmacological Research Communications, 16 (7), pp. 699-706, IF 0.470.
49. Drago, F., Sortino, G., Romano, G. Protective action of epidermal growth factor on diet-induced caries in the rat (1984) European Review for Medical and Pharmacological Sciences, 6 (4), pp. 761-764, IF 0.773.
48. Gerendai, I., Drago, F., Continella, G., Scapagnini, U. Effects of mastectomy and vagotomy on grooming behavior of the rat: Possible involvement of prolactin (1984) Physiology and Behavior, 33 (1), pp. 1-4, IF 1.250.
47. Drago, F., Continella, G., Alloro, M.C., Presti, L.L., Scapagnini, U. Behavioral effects of phosphatidylserine after perinatal administration in rats (1984) International Journal of Developmental Neuroscience, 2 (4), pp. 347-353, IF 1.406.
46. Drago, F., Continella, G., Alloro, M.C., Auditore, S., Pennisi, G. Behavioral effects of arginine in male rats (1984) Pharmacological Research Communications, 16 (9), pp. 899-907, IF 0.470.
45. Clementi, G., Drago, F., Prato, A., Cavaliere, S., Di Benedetto, A., Leone, F., Scapagnini, U., Rodolico, G. Effects of calcitonin, parathyroid hormone and its related fragments on acquisition of active avoidance behavior (1984) Physiology and Behavior, 33 (6), pp. 913-916, IF 1.250.
44. Nicoletti, F., Drago, F., Speciale, C., Kovacs, L.G., Scapagnini, U. Role of prolactin-opiate interactions in the central regulation of pain threshold (1983) Cephalalgia, 3 (Suppl. 1), pp. 31-68, IF 2.234.
43. Drago, F., van Ree, J.M., Bonus, B., Scapagnini, U., de Wied, D. Behavioral effects of prolactin: The involvement of brain dopamine (1983) Advances in the Biosciences, 44 (C), pp. 71-85, IF 0.
42. Fekete, M., Drago, F., Van Ree, J.M., Bohus, B., Wiegant, V.M., De Wied, D. Naltrexone-sensitive behavioral actions of the acth 4-9 analog (Org 2766) (1983) Life Sciences, 32 (19), pp. 2193-2204, IF 2.275.
41. Drago, F., Bohus, B., Gispen, W.H., Scapagnini, U., De Wied, D. Prolactin-enhanced grooming behavior: Interaction with ACTH (1983) Brain Research, 263 (2), pp. 277-282, IF 1.708.
40. De Kloet, E.R., Drago, F., Mezey, E., Bohus, B., De Wied, D. Pituitary stalk section transiently impairs the acquisition of shuttle box avoidance behavior (1983) Physiology and Behavior, 30 (4), pp. 499-502, IF 1.250.
39. Drago, F., Lo Presti, L., Nardo, F., Panella, I., Matera, M., Scapagnini, U. Aromatization of testosterone by adipose tissue and sexual behavior of castrated male rats (1982) Biology of Reproduction, 27 (4), pp. 765-770, IF 3.036.
38. Drago, F., Wiegant, V.M., Sapienza, G., Aguglia, E., Rapisarda, V., Scapagnini, U. Mianserin reduces plasma levels of β-endorphin immunoreactivity in depressed patients (1982) Experientia, 38 (6), pp. 685-686, IF 1.344.
37. Drago, F., Bohus, B., Van Ree, J.M., Scapagnini, U., De Wied, D. Behavioral responses of long-term hyperprolactinaemic rats (1982) European Journal of Pharmacology, 79 (3-4), pp. 323-327, IF 1.960.
36. Drago, F., Continella, G., De Luca, G. Effects of pyrimidine nucleosides and n-acetyl-glutamine on avoidance behaviour of the rat (1982) Acta Therapeutica, 8 (4), pp. 337-344, IF 0.444.
35. Drago, F., Amico-Roxas, M., Matera, M. Effects of L-acetyl-carnitine on the electroretinographic responses in patients with central retinal artery occlusion (1982) Acta Therapeutica, 8 (3), pp. 201-208, IF 0.444.
34. Drago, F., Bohus, B., Mattheij, J.A.M. Endogenous hyperprolactinaemia and avoidance behaviors of the rat (1982) Physiology and Behavior, 28 (1), pp. 1-4, IF 1.250.
33. Scapagnini, U., Drago, F., Nicoletti, F. Hormonal modulation of central dopamine receptor sensitivity in the postpartum period (1982) Psychopharmacology Bulletin, 18 (3), pp. 187-190, IF 0.
32. Drago, F., Canonico, P.L., Amico-Roxas, M. Effect of suloctidil on blood viscosity in healthy volunteers after forearm occlusion (1981) Experientia, 37 (10), pp. 1095-1096, IF 1.344.
31. Drago, F., Van Ree, J.M., Bohus, B., De Wied, D. Endogenous hyperprolactinaemia enhances amphetamine- and apomorphine-induced stereotypy (1981) European Journal of Pharmacology, 72 (2-3), pp. 249-253, IF 1.960.
30. Prato, A., Clementi, G., Nicoletti, F., Canonico, P.L., Patti, F., Condorelli, D.F., Di Giorgio, R.M., Drago, F. Possible role of prolactin in the modification of medial basal hypothalamic glutamic acid decarboxylase activity (1981) European Journal of Pharmacology, 71 (1), pp. 169-172, IF 1.960.
29. Drago, F., Bohus, B. Hyperprolactinemia-induced excessive grooming in the rat: time-course and element analysis (1981) Behavioral and Neural Biology, 33 (1), pp. 117-122, IF 0.
28. Moro, R., Scapagnini, U., Scaletta, S., Drago, F. Serotonin nerve endings and regulation of pupillary diameter (1981) Annals of Ophthalmology, 13 (4), pp. 487-490, IF 0.126.
27. Drago, F., Canonico, P.L., Scapagnini, U. Behavioral effects of phosphatidylserine in aged rats (1981) Neurobiology of Aging, 2 (3), pp. 209-213, IF 2.872.
26. Drago, F., Bohus, B., Van Ree, J.M. Involvement of brain dopamine in the behavioral effects of prolactin (1981) Neuroendocrinology Letters, 3 (2), p. 100, IF 0.791.
25. Drago, F., Lo Presti, L., Bitetti, R., Canonico, P.L. Effects of variated levels of plasma prolactin on sexual behavior of male rats (1981) Journal of Steroid Biochemistry, 14 (11), pp. No. 70, IF 1.709.
24. Drago, F., Pellegrini-Quarantotti, B., Scapagnini, U., Gessa, G.L. Short-term endogenous hyperprolactinaemia and sexual behavior of male rats (1981) Physiology and Behavior, 26 (2), pp. 277-279, IF 1.250.
23. Drago, F., Bohus, B., Canonico, P.L., Scapagnini, U. Prolactin induces grooming in the rat: Possible involvement of nigrostriatal dopaminergic system (1981) Pharmacology, Biochemistry and Behavior, 15 (1), pp. 61-63, IF 1.480.
22. Drago, F., Bohus, B., De Wied, D. Interaction between vasopressin and oxytocin in the modulation of passive avoidance retention of the rat (1981) Neuroscience Letters, 24 (SUPPL.7), pp. S260, IF 1.768.
21. Drago, F., Rapisarda, V., Calandra, C. A clinical evaluation of the effects of vasopressin on memory disorders (1981) Acta Therapeutica, 7 (4), pp. 345-352, IF 0.444.
20. Spina, F., Gorgone, G., Drago, F., Viola, M. Penetration of marked antibiotics in the lacrimal gland [PENETRAZIONE DI ANTIBIOTICI MARCATI NELLA GHIANDOLA LACRIMALE. RICERCHE SPERIMENTALI] (1981) Clinica Oculistica e Patologia Oculare, 2 (1), pp. 77-80, IF 0.
19. Amico-Roxas, M., Drago, F., Canonico, P.L., Russo, A., Terranova, R., Spitaleri, A., Bianchi, A. Plasma viscosity: Relation to age, atherogenic diet and suloctidil (1981) Pharmacological Research Communications, 13 (8), pp. 765-767, IF 0.470.
18. Rampello, L., Nicoletti, F., Patti, F., Condorelli, D.F., Drago, F., Maugeri, S., Prestifilippo, N., Patané, C., Reggio, A., Raffaele, R. Evaluation of motor behavior in hyperprolactinemic conditions [Valutazione del behavior motorio in condizioni di iperprolattinemia.] (1981) Acta neurologica. Quaderni, 42, pp. 297-301, IF 0.444.
17. Canonico, P.L., Annunziato, L., Toffano, G., Bernardini, R., Stanzani, S., Foti, M., Clementi, G., Drago, F., Scapagnini, U. In vivo and in vitro interference of phosphatidylserine liposomes on prolactin secretion in the rat (1981) Neuroendocrinology, 33 (6), pp. 358-362, IF 2.441.
16. Drago, F., Amico-Roxas, M., Russo, A., Bianchi, A., Mazzoleni, G. Effects of suloctidil on plasma viscosity of the rat [EFFETTI DEL SULOCTIDIL SULLA VISCOSITA PLASMATICA IN RATTI A DIETA ATEROGENA] (1980) Farmaco, Edizione Pratica, 35 (8), pp. 423-426, IF 0.
15. Drago, F., Gorgone, G., Spina, F., Panissidi, G., Bello, A.D., Moro, F., Scapagnini, U. Opiate receptors in the rabbit iris (1980) Naunyn-Schmiedeberg’s Archives of Pharmacology, 315 (1), pp. 1-4, IF 2.451.
14. Moro, F., Drago, F. Endocrine optic neuropathies (1980) Documenta Ophthalmologica, 49 (2), pp. 361-367, IF 0.450.
13. Rapisarda, V., Fichera, G., Drago, F., Amico-Roxas, M. Effects of mazindol in some cases of psychic obesity [EFFETTI DEL MAZINDOLO SU ALCUNI CASI DI OBESITA’ PSICHICA] (1980) Formazione Psichiatrica, No. 1, pp. 54-62, IF 0, 235.
12. Drago, F., Bohus, B., Scapagnini, U., De Wied, D. Sexual dimorphism in passive avoidance behavior of rats: Relation to body weight, age, shock intensity and retention interval (1980) Physiology and Behavior, 24 (6), pp. 1161-1164, IF 1.250.
11. Calandra, C., Drago, F., Filetti, S. A case of involving memory disturbances treated with vasopressin [SU UN CASO CON TURBE MNESTICHE TRATTATO CON VASOPRESSINA] (1980) Minerva Psichiatrica, 21 (1), pp. 63-66, IF 0.
10. Drago, F., Canonico, P.L., Bitetti, R., Scapagnini, U. Systematic and intraventricular prolactin induces excessive grooming (1980) European Journal of Pharmacology, 65 (4), pp. 457-458, IF 1.960.
9. Scapagnini, U., Canonico, P.L., Drago, F. Psychoneuroendocrine effects of prolactin [AZIONI PSICONEUROENDOCRINE DELLA PROLATTINA] (1980) Formazione Psichiatrica, No. 3, pp. 30-50, IF 0, 235.
8. Drago, F., Rapisarda, V., Aguglia, E., Sapienza, G. Effect of neuroleptic drugs on plasma levels of beta-endorphin [EFFETTI DEI NEUROLETTICI SUI LIVELLI PLASMATICI DI β-ENDORFINA] (1980) Formazione Psichiatrica, No. 1, pp. 8-15, IF 0, 235.
7. Prato, A., Amico-Roxas, M., Canonico, P.L., Drago, F., Clementi, G. In vitro and in vivo antiserotoninergic effects of 1-isopropylnoradreno-chrome-5-monosemicarbazone (divascan®) (1980) Pharmacological Research Communications, 12 (8), pp. 751-756, IF 0.470.
6. Gerendai, I., Wenger, T., Marchetti, B., Clementi, G., Prato, A., Canonico, P.L., Drago, F., D’Agata, R., Scapagnini, U. Monoaminergic regulation of lhrh in the organon vasculosum of lamina terminalls (OVLT) (1980) Pharmacological Research Communications, 12 (4), pp. 385-391, IF 0.470.
5. Drago, F., Di Dino, G., Lo Presti, L. A rare anomaly of flexor carpi ulnaris muscle associated to absence of palmaris longus [RARA ANOMALIA DEL MUSCOLO FLESSORE ULNARE DEL CARPO ASSOCIATA AD ASSENZA DEL MUSCOLO PALMARE LUNGO] (1979) Archivio Italiano di Anatomia e di Embriologia, 84 (1), pp. 71-80, IF 0.
4. Moro, F., Scapagnini, U., Gorgone, G., Reina, R., Scaletta, S., Drago, F. Chronic degeneration of aminergic nerve endings and blood-aqueous barrier – Experimental evidence (1979) Albrecht von Graefes Archiv für Klinische und Experimentelle Ophthalmologie, 209 (4), pp. 225-230, IF 0.
3. Matera, M., Amico-Roxas, M., Fiore, L., Prato, A., Clementi, G., Corsello, S., Drago, F., Guarcello, V. The influence of hematoporphyrin on tonic or phasic prolactin secretion [INFLUENZA DELL’EMATOPORFIRINA SULLA SECREZIONE TONICA O FASICA DELLA PROLATTINA] (1979) Clinica Terapeutica, 88 (2), pp. 183-193, IF 0,351.
2. Bianchi, A., Drago, F., Canonico, P.L., Guarcello, V., Carpiniello, B., Scapagnini, U. Neuroendocrine effects of bromperidol (1978) Acta Psychiatrica Belgica, 78 (1), pp. 69-82, IF 0.
1. Amico Roxas, M., Matera, M., Cannava, N., Drago, F. Central muscle relaxant activity of a new Benzodiazepine derivative: Prazepam [ATTIVITA MIORILASSANTE CENTRALE DI UN NUOVO BENZODIAZEPINICO: IL PRAZEPAM] (1977) Clinica Terapeutica, 80 (2), pp. 159-165, IF 0,351.